日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  17(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture Several Efforts to Conquer Cancer / Y.Hikasa / p217~217
  • Memorial Lecture 1.Eighteen Years in which Japan Society for Cancer Therapy has Traced / K.Nakayama / p218~218
  • Memorial Lecture 2.Retrospection on Surgery of Gastric Cancer / T.Kajitani / p219~219
  • Special Lecture 1.Hormone Receptors and Hormone-dependency of Cancer / K.Matsumoto / p220~220
  • Special Lecture 2.The Corticotropin-β-lipotropin Precursor Gene: Structure and Expression in Normal Neoplastic Tissues / S.Numa / p221~221
  • Special Lecture 3.Epidemiological Consideration on Cancer--Interaction of Host and Environment in Childhood / K.Aoki / p222~222
  • Special Lecture 4.Cloning of Human Tumor Stem Cells:Role in Cancer Treatment and New Drug Development / S.E.Salmon / p223~240
  • Special Lecture 5.Pancreatic Cancer / I.Cohn,Jr. / p241~249
  • Special Lecture 6.Localized Hyperthermia in the Treatment of Cancer / F.K.Storm / p250~281
  • Lecture Reco㎜ended by President A-1.Treatment for Malignant Ovarian Tumors / M.Yakushiji / p282~282
  • Lecture Reco㎜ended by President A-2.Transplacental Hormonal Carcinogenesis and Teratogenesis / K.Hoshino / p283~283
  • Lecture Reco㎜ended by President B-1.The Hereditary Neoplasm of the Large Bowel / J.Utsunomiya / p284~284
  • Lecture Reco㎜ended by President B-2.Some Problems in the Early Diagnosis of Colon Cancer / M.Tada / p285~285
  • Lecture Reco㎜ended by President C-1.TdT Activity and Vincristine-Prednisolone Therapy in Blast Crisis of Chronic Myelogenous Leukemia / S.Sakamoto et al. / p286~286
  • Lecture Reco㎜ended by President C-2.Microencapsulation of Anticancer Drugs and Its Clinical Application / T.Kato / p287~287
  • Lecture Reco㎜ended by President D-1.Immunochemotherapy with Transfer Factor for Primary Lung Cancer Patients / T.Fujisawa / p288~288
  • Lecture Reco㎜ended by President D-2.Tracheobronchial Plasty for Lung Cancer / M.Maeda / p289~289
  • Lecture Reco㎜ended by President E-1.Intraoperative Radiotherapy for Refractory Cancer / M.Abe et al. / p290~290
  • Lecture Reco㎜ended by President E-2.Single Photon Emission Computed Tomography / T.Maeda et al. / p291~291
  • Lecture Reco㎜ended by President F-1.The Phenomenon of Spontaneous Regression of Flat Warts / H.Tagami / p292~292
  • Lecture Reco㎜ended by President F-2.Functional Characteristic of Tumor Vessels,with Reference to Enhancement of the Drug Delivery / M.Suzuki / p293~293
  • Lecture Reco㎜ended by President G.Primary Reconstructive Surgery in Head and Neck Cancer--Evaluation of Long-term Survival Rate and Functional and Cosmetic Effect / A.Konno / p294~294
  • Symposium 1 Problems in Treatment of Malignancies of Pelvic Cavity / / p295~301
  • Symposium 1 1.The Problems in the Treatment of Cervical Cancer / H.Okuda / p295~295
  • Symposium 1 2.Surgical Treatment for Carcinoma of the Uterine Cervix / A.Suzuki / p296~296
  • Symposium 1 3.Problems on the Treatment of Malignant Tumors in the Pelvis--Bladder Tumor / K.Koiso / p297~297
  • Symposium 1 4.The Management of Bladder Cancer / O.Yoshida / p298~298
  • Symposium 1 5.Rectal Cancer--End Results and Functional Disturbances in Abdominoperineal Resection and Sphincter Saving Procedures with or without Extended Lymph Nodes Dissection / Y.Koyama / p299~299
  • Symposium 1 6.Treatment of Malignancies of the Intrapelvic Organ: Carcinoma of the Rectum / K.Kato / p300~300
  • Symposium 1 7.Problems in Treatment for Malignant Tumors in the Pelvis / S.Mochizuki / p301~301
  • Symposium 2 Present Status of Mass-screening in Japan / / p302~310
  • Symposium 2 1.Mass-screening of Uterine Cancer in Chiba Prefecture / T.Kasai / p302~302
  • Symposium 2 Utterance Results in Cytology Mass-screening of the Uterine Cancer by Tobo Method / T.Hasegawa / p303~303
  • Symposium 2 2.Current Problems in Mass Screening for Breast Cancer / K.Yoshida / p304~304
  • Symposium 2 3.Mass Screening Program for Prostatic Cancer by Means of Transrectal Ultrasonotomography / H.Ohe / p305~305
  • Symposium 2 Utterance Cytologic Examination of the Urine as a Mass Screening of the Urinary Bladder Cancer / T.Yamada / p306~306
  • Symposium 2 4.The Present Aspect of a Mass Screening for Lung Cancer / J.Tamada / p307~307
  • Symposium 2 Utterance Results of a Long Term Lung Cancer Survey / Y.Hayata / p308~308
  • Symposium 2 5.Mass Survey for Stomach Cancer / K.Tamura / p308~309
  • Symposium 2 Utterance Mass Screening for Colorectal Cancer / S.Kobayashi / p309~309
  • Symposium 2 6.Results and Some Problems of Mass Screening of Neuroblastoma in Infancy / T.Sawada / p310~310
  • Symposium 3 Problems in Primary Liver Cancer / / p311~319
  • Symposium 3 1.Pathological Considerations on Hepatocellular Carcinoma / M.Okudaira et al. / p311~311
  • Symposium 3 2.Pathology of Hepatocellular Carcinoma--A Study of Histological Growth Pattern and Tumor Vessels / T.Nakashima et al. / p312~312
  • Symposium 3 Utterance Hepatocellular Carcinoma with or without Liver Cirrhosis / W.Mori / p313~313
  • Symposium 3 3.High Risk Group of Liver Cell Carcinoma / N.Hattori et al. / p313~313
  • Symposium 3 4.Not Received / /
  • Symposium 3 Utterance Diagnostic Significance of Hepatoma Specific Gamma-Glutamyltranspeptidase / K.Fujisawa et al. / p314~314
  • Symposium 3 5.Angiographic Diagnosis of Hepatoma and Its Application for Transarterial Treatment / K.Hiramatsu et al. / p314~315
  • Symposium 3 6.Not Received / /
  • Symposium 3 Utterance Embolization of Hepatoma Findings on Follow-up CT with Evaluation of Tumor and Liver Volume / S.Furui et al. / p315~315
  • Symposium 3 7.Operative Results of Hepatic Lobectomy for Primary Hepatoma / K.Sugahara et al. / p316~316
  • Symposium 3 8.The Present Status of Surgical Treatments of Hepatoma in our Clinic / E.Okamoto / p317~317
  • Symposium 3 Utterance Aggressive Surgery and Postoperative Support against Liver Cancer / H.Hasegawa / p318~318
  • Symposium 3 9.Viral Hepatitis and Hepatoma / K.Nishioka / p319~319
  • Symposium 4 Tumors Associated Syndromes / / p320~326
  • Symposium 4 1.Hypercalcemia / K.Abe / p320~320
  • Symposium 4 2.Hyponatremia and SIADH / T.Kimura et al. / p321~321
  • Symposium 4 3.Hypokalemia and Hyperadrenocorticism / S.Matsukura et al. / p322~322
  • Symposium 4 4.Extrapancreatic Tumors Associated with Hypoglycemia in Japan / M.Okuyama / p323~323
  • Symposium 4 5.Erythrocytosis and Leukocytosis Associated with Malignant Tumors / F.Takaku et al. / p324~324
  • Symposium 4 6.Some Clinical Aspects of DIC Associated with Malignant Tumor / K.Kumada et al. / p325~325
  • Symposium 4 7.Neuromuscular Involvement in Malignancy / H.Nishitani / p326~326
  • Symposium 5 Future of Cancer Therapy / / p327~332
  • Symposium 5 1.Present Situation of Cancer Patients and Cancer Control Programs in Japan / T.Furukawa / p327~327
  • Symposium 5 2.Future Outlook for Therapy of Carcinoma of the Breast / K.Kuno / p328~328
  • Symposium 5 3.Future of Lung Cancer Therapy / Y.Hayata / p328~328
  • Symposium 5 4.Not Received / /
  • Symposium 5 5.The Future Image of the Diagnostic Techniques and Treatments of the Liver, Pancreas and Bile Duct Cancer / H.Hasegawa / p329~329
  • Symposium 5 6.The Future of the Treatment of Gynecological Malignancies / K.Noda / p330~330
  • Symposium 5 7.Cancer Chemotherapy from Experimental Standpoints / S.Tsukagoshi / p330~331
  • Symposium 5 8.Perspective of Cancer Chemotherapy / K.Kimura / p331~332
  • Symposium 5 9.Radiotherapy in Future / Y.Umegaki / p332~332
  • Panel Discussion Local Therapy against Recurrence of Cancer / / p333~340
  • Panel Discussion 1.Cryosurgery and Cryochemotherapy for the Treatment of Local Recurrent Cancer / S.Tanaka / p333~333
  • Panel Discussion 2.Clinical Experience with Thermotherapy to Recurrent Malignant Tumors after Radiotherapy / M.Hiraoka et al. / p333~333
  • Panel Discussion 3.Laser Surgery for the Local Recurrence Cases of Head and Neck Tumors / M.Nakata et al. / p334~334
  • Panel Discussion 4.Therapeutic Results of Wide Resection in Recurrent Cancer of the Head and Neck / M.Uchida / p334~334
  • Panel Discussion 5.Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of the Metastatic Skin Lesion from Breast Cancer / H.Kato et al. / p335~335
  • Panel Discussion 6.Reconstructive Method of Anterior Chest Wall after Wide Resection--Evaluation of the Usefulness of Acrylic Resin / S.Noguchi / p335~335
  • Panel Discussion 7.The Treatment of Recurrent Esophageal Cancer / S.Onoda et al. / p336~336
  • Panel Discussion 8.Effect of a Slow-Releasing Anticancer Agent(Solid Bleomycin Tube)on Recurrent Metastatic Lymph Nodes / H.Watanabe et al. / p336~336
  • Panel Discussion 9.Resection of Locally Recurred Cancer of the Stomach / K.Miwa et al. / p337~337
  • Panel Discussion 10.Intratumoral Large-dose Administration of OK-432 in Patients with Recurrent Gastric Cancer / M.Niimoto et al. / p337~337
  • Panel Discussion 11.Continuous Hyperthermic Peritoneal Perfusion for the Patients with Peritoneal Dissemination / M.Maeta et al. / p338~338
  • Panel Discussion 12.Endoscopic Cryosurgery for Recurrent Gastric Cancer / T.Yamasaki et al. / p338~338
  • Panel Discussion 13.Clinical Application of Microencapsulated Anticancer Drug: V.Antitumor Effect on Locally Recurrent Carcinoma in Pelvis / R.Nemoto et al. / p339~339
  • Panel Discussion 14.A New Approach with the Combined Therapy for Recurrent Gynecological Malignancies: A Trial of Thermochemotherapy and Cryochemotherapy / I.Kohno et al. / p339~339
  • Panel Discussion 15.Balloon Occluded Arterial Infusion of Anticancer Drug for Recurrent Carcinoma / H.Nakatsuka et al. / p340~340
  • Workshop Diagnosis and Treatment for Cancer--Its Blind Spots / / p341~428
  • Workshop1 Biochemical Assays / / p341~347
  • Workshop1 1.Usefulness of 5'-Nucreotide Phosphodiesterase Isoenzyme-V(5'-NPD-V)for Diagnosing Liver Metastasis / M.Nakada et al. / p341~341
  • Workshop1 2.Not Received / /
  • Workshop1 3.A Simple Enzymatic Assay for Diamines and Polyamines and Its Clinical Application / T.Matsumoto et al. / p341~341
  • Workshop1 4.α2-PA Glycoprotein as a Parameter in Diagnosis and Clinical Course of Lung Cancer / H.Maruishi et al. / p342~342
  • Workshop1 5.Pregnancy-associated α2-glycoprotein in Patients with Ovarian Cancer / Y.Shimizu et al. / p342~342
  • Workshop1 6.The Use of CEA Slope Analysis as an Indicator of Early Recurrence in Patients with Gastrointestinal Breast Carcinoma / S.Akai et al. / p343~343
  • Workshop1 7.Early Detection of Recurrent Gastric Cancer by Serum CEA Level / R.Tamada et al. / p343~343
  • Workshop1 8.Diagnostic Evaluation of Carcinoembryonic Antigen in Pleural Fluid / M.Takada et al. / p344~344
  • Workshop1 9.Clinical Significance of Bile CEA Level in the Diagnosis of Malignant Biliary and Pancreatic Diseases / Y.Watanabe et al. / p344~344
  • Workshop1 10.Severe Nephropathy Induced by the Deposition of CEA-immune Complex / T.Mori et al. / p345~345
  • Workshop1 11.Pitfalls in Ferritin Assay in Malignancy and Its countermeasurement / Y.Kohgo et al. / p345~345
  • Workshop1 12.Evaluation of Alpha-fetoprotein as the Tumor Marker in the Clinical Course of 44 Non-seminomatous Testicular Tumors / M.Yanagisawa / p346~346
  • Workshop1 13.Significance of Basic Fetoprotein in Uro-genital Disease: Clinical Usefulness as a Testicular Tumor Marker / H.Nagata et al. / p346~346
  • Workshop1 14.Diagnosis of Choriocarcinoma Using Radioimmunological Measurement of B-hCG,SP1 and PP5 / T.Saito et al. / p347~347
  • Workshop1 15.Diagnostic Value in Malignant Digestive Disease Using Three Kinds of Tumor Markers,Basic Fetoprotein(BFP),Carcinoembryonic Antigen(CEA),Alpha-Fetoprotein(AFP) / Y.Kanda et al. / p347~347
  • Workshop2 Imaging Examination / / p348~355
  • Workshop2 1.Pitfalls of Medical Imagings--Diagnostic Modalities in Recognizing Hepatoma / K.Kawahira et al. / p348~348
  • Workshop2 2.Angiographic CT (Angio-CT) / N.Moriyama / p348~348
  • Workshop2 3.Ultrasonographic Findings of Hepatoma,Particularly in Minute Hepatoma / Y.Majima et al. / p349~349
  • Workshop2 4.Significance of Ultrasonography in the Early Stage of Hepatocellular Carcinoma / A.Saitoh et al. / p349~349
  • Workshop2 5.Clinical Usefulness and Limitation of Emission Computed Tomography for Detecting Small Liver Tumors / K.Yamamoto et al. / p350~350
  • Workshop2 6.Pitfalls in Diagnostic imaging of Hepatoma and Carcinoma of the Bifurcation of the Hepatic Ducts / S.Iida et al. / p350~350
  • Workshop2 7.Evaluation of Image Diagnostic Modalities in Laparotomized Patients for Hepatectomy--Intraoperative Ultrasonic Examination(10-US),Preoperative Ultrasonic Examination(P-US),CT and Angiography / M.Makuuchi et al. / p351~351
  • Workshop2 8.Preoperatively Staging of Gastric Cancer Using Image Diagnostic Tools such as CT and US / M.Ozaki et al. / p351~351
  • Workshop2 9.Criteria for the Assessment of Chemotherapy of Borrmann Type 4 Gastric Cancer / M.Kurihara et al. / p352~352
  • Workshop2 10.CT as a Quide to the Operation of the Recal Carcinoma / Y.Tsujinaka et al. / p352~352
  • Workshop2 11.Diagnostic Imaging of Bile Duct Carcinoma / S.Shimaguchi et al. / p353~353
  • Workshop2 12.The Pitfall of the Radiological Diagnosis for Bile Duct Cancer and Percutaneous Transhepatic Cholangioscopy (PTCS) / Y.Nimura et al. / p353~353
  • Workshop2 13.Pitfalls in Sonographic Diagnosis of Pancreatic Cancer / T.Miyashita et al. / p354~354
  • Workshop2 14.Evaluation of Diagnostic Procedure of CT in the Kidney / B.Suyama et al. / p354~354
  • Workshop2 15.Comparison of Computed Tomography and Angiography in the Evaluation of Renal Cell Carcinoma / T.Onishi et al. / p355~355
  • Workshop2 16.Diagnosis of Ovarian Tumor by Ultrasonography,Computerized Tomography and Scintigraphy / S.Doi et al. / p355~355
  • Workshop3 Chemotherapy--Leukemia / / p356~360
  • Workshop3 1.Evalution of Prognostic Factors and Risk Point Scoring System of Children with Acute Lymphoblastic Leukemia / K.Iguchi et al. / p356~356
  • Workshop3 2.High-dose Methotrexate with Citrovorum Factor Rescue in Refractory Adult Acute Lymphocytic Leukemia / Y.Fujiwara et al. / p356~356
  • Workshop3 3.BH-AC・AMP Combination Chemotherapy of Patients with Acute Nonlymphocytic Leukemia in Relapse / H.Suzuki et al. / p357~357
  • Workshop3 4.A Pilot Study Using High Doses of Daunomycin and Cytosine Arabinoside for Induction Therapy of AML / H.Taguchi et al. / p357~357
  • Workshop3 5.Action Mechanism of Aclacinomycin A(ACM) in Leukemic Cells and Its Clinical Effects / T.Nakamura et al. / p358~358
  • Workshop3 6.Prophylactic Chemotherapy for Acute Blastic Transformation of Chronic Myelocytic Leukemia / K.Okada et al. / p358~358
  • Workshop3 7.Chemotherapy for the Blastic Crisis in CML / K.Kitajima et al. / p359~359
  • Workshop3 8.Schedule Dependency in Combination Chemotherapy with Ara C Group and Anthracycline Group / Y.Sakai et al. / p359~359
  • Workshop3 9.Hemostatic Abnormalities in Hematopoietic Malignancy: Chemotherapy and DIC / M.Kuto et al. / p360~360
  • Workshop3 10.Therapy of Erythroleukemia and RAEM / H.Sawada et al. / p360~360
  • Workshop4 Chemotherapy--SolidCancer / / p361~368
  • Workshop4 1.Chemotherapy of Head and Neck Cancer--Recent Progress and Prospect / Y.Inuyama et al. / p361~361
  • Workshop4 2.Results of Summary of the Controlled Study in the Chemotherapy of a Small Cell Bronchogenic Carcinoma in Lung Cancer Chemotherapy Groups of National Hospitais and Sanatorium / H.Komatsu et al. / p361~361
  • Workshop4 3.Brain Metastasis of Small Cell Lung Cancer--Retrospective Analysis of Prophylactic Brain Radiation / Y.Nakata et al. / p362~362
  • Workshop4 4.Pitfalls of Chemotherapy for Inoperable Non-small Cell Lung Cancer / M.Kawahara et al. / p362~362
  • Workshop4 5.Chemotherapy for Advanced Lung Cancer--Response and Prognostic Factors / M.Fukuoka et al. / p363~363
  • Workshop4 6.Postoperative Chemotherapy in Gastric Cancer--With MFC Therapy as the Predominance / H.Sato et al. / p363~363
  • Workshop4 7.UFTM-chemotherapy for Gastric Cancer / S.Suga et al. / p364~364
  • Workshop4 8.Disease State Representation and Prediction of Prognoses for Advanced Gastric Cancer Patients / H.Takahashi et al. / p364~364
  • Workshop4 9.A Study of Adjuvant Chemotherapy at Time of Operation for Colo-rectal Cancer,Especially Subserosal Administration Method / A.Yagita et al. / p365~365
  • Workshop4 10.Treatment of Hepatocellular Carcinoma by Intra-arterial One Shot Injection of Anticancer Drugs / K.Hirai et al. / p365~365
  • Workshop4 11.Changes of the Tumor Vesseles Following Intra-arterial Infusion Therapy Using a Combination of Mitomycin and Dexamethazone / K.Satomura et al. / p366~366
  • Workshop4 12.Effect of Cancer Chemotherapy for Unresectable Cancer of the Pancreas / Y.Kinami et al. / p366~366
  • Workshop4 13.Brain Metastasis and Damage of Spermatogenesis during Combination Chemotherapy for Disseminated Germinal Cell Carcinoma of the Testis / T.Kiriyama et al. / p367~367
  • Workshop4 14.Clinical Results of Induced Hypertension Chemotherapy with Angiotensin II / Y.Sato et al. / p367~367
  • Workshop4 15.High Dose Combination Chemotherapy with Autologous Bone Marrow Transplantation in Cancer Patients / A.Hiraiwa et al. / p368~368
  • Workshop5 Multimodulated Therapy Combined with Surgery--Brain and Neck / / p369~380
  • Workshop5 1.The Effects of Fibroblast Interferon(F-IF)on the Transplanted Human Malignant Gliomas to the Nude Mice and on the Clinical Cases / Y.Miki et al. / p369~369
  • Workshop5 2.Interferon Therapy on Malignant Brain Tumors--Special Reference to the Intratumorous and Intrathecal Administration / M.Nagai et al. / p369~369
  • Workshop5 3.Extensive Surgical Removal of Glioblastoma after Radiotherapy / M.Matsutani et al. / p370~370
  • Workshop5 4.Preoperative Radiotherapy and Radical Removal of Malignant Brain Tumors / T.Kondo et al. / p370~370
  • Workshop5 5.High-dosage BCNU and Autologous Bone Marrow Grafting for Pediatric Brain Tumors / K.Kuwamura et al. / p371~371
  • Workshop5 6.Multimodality Treatment of Malignant Glioma,Effect of Immunotherapy with N-CWS / J.Yoshida et al. / p371~371
  • Workshop5 7.ACNU and PSK Therapy after the Surgical Treatment of the Malignant Intracranial Tumors (Especially Cases of Long Term Survival) / K.Muraoka et al. / p372~372
  • Workshop5 8.Clinical Application of Iridium-192 in Recurrent Glioma / K.Nomura et al. / p372~372
  • Workshop5 9.Comparative Study of Multimodality Treatment for Malignant Brain Tumors / K.Harada et al. / p373~373
  • Workshop5 10.Assessment of Surgical Treatment Combined with Chemotherapy for Cerebral Metastasis of Choriocarcinoma / T.Ishizuka et al. / p373~373
  • Workshop5 11.The Diagnosis and Treatment of Brain Metastasis of Lung Cancer--Correlation between Histological Types and CT Findings / T.Kobayashi et al. / p374~374
  • Workshop5 12.Problems of Multidisciplinary Treatment of Cancer in the Head and Neck / K.Sugita et al. / p374~374
  • Workshop5 13.Combined Therapy for Maxillary Sinus Carcinoma,with Special Reference to Contribution of Surgery / S.Sakai et al. / p375~375
  • Workshop5 14.Results and Changes of Our Combined Therapy for Maxillary Cancer / H.Saito et al. / p375~375
  • Workshop5 15.Reconsideration of the Combined Treatment by Surgery,Chemotherapy and Radiation for Cancer of the Maxillary Sinus / Y.Matsumura et al. / p376~376
  • Workshop5 16.A Combined Therapy of Surgery,Radiotherapy, Regional Chemotherapy and BCG Immunotherapy in Cancer of the Maxilla / H.Takahashi et al. / p376~376
  • Workshop5 17.Pitfall of the Diagnosis and Treatment for Undifferentiated Carcinoma of the Thyroid Gland / Y.Tanaka et al. / p377~377
  • Workshop5 18.The Choice of Treatment in Thyroid Carcinoma with the Lower Transformation: If You Find the Poorly Differentiated or Anaplastic Transformation of Thyroid Carcinoma,How do You Treat Them? / N.Kasai et al. / p377~377
  • Workshop5 19.Resection of Thyroid Carcinoma Infiltrating the Trachea / T.Ishihara et al. / p378~378
  • Workshop5 20.Surgical Salvage of Radiation Failures in the Treatment of Carcinoma of the Tongue / I.Ono. / p378~378
  • Workshop5 21.Some Remarks on a Combination Therapy of Hypopharyngeal Cancer / Y.Murakami et al. / p379~379
  • Workshop5 22.Post-laryngectomy Tracheal Stomal Recurrence Following Emergency Tracheostomy / S.Komiyama et al. / p379~379
  • Workshop5 23.New Surgical Trial for Carcinoma of the Tongue Base / K.Sugimoto et al. / p380~380
  • Workshop 6 Multimodulated Therapy Combined with Surgery--Thorax and Breast / / p381~389
  • Workshop 6 1.Study on Operative Cases of Mediastinal Tumor,Especially Treatment of Malignant Mediastinal Tumor Combined with Operation / M.Imaizumi et al. / p381~381
  • Workshop 6 2.PostoPerative Prognosis of the Surgically Treated Patients with Primary Adenocarcinoma of the Lung with Mediastinal Lymph Node Metastases / S.Fukai et al. / p381~381
  • Workshop 6 3.Adjuvant Therapy of Lung Cancer / K.Kunishima et al. / p382~382
  • Workshop 6 4.Post-operative Chemotherapy for Lung Cancer--In vivo Sensitivity Test of Anti-cancer Drugs and Their Effective Concentration in the Peripheral Blood / M.Kitano et al. / p382~382
  • Workshop 6 5.Anticancer Chemotherapy Adjunct to the Resection of Lung Cancer / E.Akaogi et al. / p383~383
  • Workshop 6 6.Results of Adjuvant Therapy of 4,931 Cases with Lung Cancer--Results of Field Study in Japan / K.Yoshimura et al. / p383~383
  • Workshop 6 7.Hematoporphyrin Derivative(HpD)and Laser Photoradiation in the Treatment of Lung Cancer / C.Konaka et al. / p384~384
  • Workshop 6 8.The Evaluation of Surgical Treatment Combined with Chemotherapy for Pulmonary Metastases of Choriocarcinoma / Y.Nishikawa et al. / p384~384
  • Workshop 6 9.Not Received / /
  • Workshop 6 10.A New Operative Method of Extended Radical Mastectomy and an Analysis of Its 43 Performed Cases / M.Noguchi et al. / p385~385
  • Workshop 6 11.Problems in Prophylactic Irradiation for Mammary Carcinoma and Some Trials to Improve Patient's Prognosis / Y.Koike et al. / p385~385
  • Workshop 6 12.Adjuvant Chemotherapy with Modified CMF Combination for Breast Cancer / Y.Uekita et al. / p386~386
  • Workshop 6 13.Combined Therapy on Stage III Breast Cancer and Its Therapeutic Policy in Our Department / T.Ueda et al / p386~386
  • Workshop 6 14.Surgical Adjuvant Chemotherapy for Breast Cancer / T.Morimoto et al. / p387~387
  • Workshop 6 15.Prognostic Factors and Adjuvant Therapy in Cancer of the Breast with 8 or More Involved Axillary Nodes / S.Miura et al. / p387~387
  • Workshop 6 16.Multidisciplinary Treatment for Locally Advanced Breast Cancer / H.Koyama et al. / p388~388
  • Workshop 6 17.Non-specific Immunity of Breast Cancer Patients and Effect of Levamisole(LMS)& Krestin(PSK)Using with Post-operative Adjuvant Chemotherapy in Breast Cancer Patients / K.Hoshino et al. / p388~388
  • Workshop 6 18.Immune Responses in the Treatment of Advanced Carcinoma of the Breast Effect of Adreno-oophorectomy / M.Akimoto et al. / p389~389
  • Workshop 7 Multimodulated Therapy Combined with Surgery--Esophagus and Abdomen / / p390~395
  • Workshop 7 l.Adjuvant Cancer Chemotherapy for Carcinoma of the Esophagus / K.Sugimachi et al. / p390~390
  • Workshop 7 2.The Effect of Fast Neutron as a Combined Therapy for Esophageal Carcinoma / K.Isono et al. / p390~390
  • Workshop 7 3.Multidisciplinary Treatment for Esophageal Carcinoma / T.Iizuka et al. / p391~391
  • Workshop 7 4.Effects of Pre-operative Irradiation Combined with Intra-tumor Injection of Pepleomycin(PLM)and BUdR(5-bromodeoxy-uridine)on Growth and Survival in a Mouse Fibrosarcoma, and on Advanced Human Carcinoma of the Rectum in Lower Portion / T.Todoroki et al. / p391~391
  • Workshop 7 5.Surgery and Combination Therapy in Esophageal Cancer Cases with Special Reference to Postoperative Prophylactic Irradiation of the Neck and Upper Mediastinum / H.Ide et al. / p392~392
  • Workshop 7 6.Clinical Studies of Resected Esophageal Carcinoma Following Radiation Therapy of Over 5,000 Rad / H.Koizumi et al. / p392~392
  • Workshop 7 7.Extension of Upper Gastric Carcinoma and Operative Procedure / Y.Omori et al. / p393~393
  • Workshop 7 8.Is a Splenectomy an Useful Method in an Operation for a Gastric Cancer? / K.Yoshino et al. / p393~393
  • Workshop 7 9.Chemo-endocrine Therapy for Diffuse Carcinoma of the Stomach / H.Kitaoka et al. / p394~394
  • Workshop 7 10.Continuous Hyperthermic Peritoneal Perfusion(CHPP)for Prevention of Peritoneal Dissemination / N.Shimizu et al. / p394~394
  • Workshop 7 11.Combined Therapy of Surgical Treatment of the Extra Hepatic Bile Duct Cancer / T.Kobayashi et al. / p395~395
  • Workshop 7 12.Problems in Treatment for Hepatic Cancer--Anticancer Treatment with Oily Anticancer Drug Injected into the Hepatic Artery / S.Tashiro et al. / p395~395
  • Workshop 7 13.Not Received / /
  • Workshop 8 Multimodulated Therapy Combined with Surgery--Urogenital Organ / / p396~399
  • Workshop 8 1.Evaluation of Treatment for Renal Cell Carcinoma / F.Masuda et al. / p396~396
  • Workshop 8 2.Pitfall in the Multidisciplinary Treatment for High Stage Cancer of the Urinary Bladder / M.Miyakawa et al. / p396~396
  • Workshop 8 3.Clinical Studies on Recurrence Rate of Superficial Bladder Tumor by Intravesical Instillation / A.Maru et al. / p397~397
  • Workshop 8 4.Combination Chemotherapy,Radiation Therapy and Surgery for Testicular Cancer / S.Noda et al. / p397~397
  • Workshop 8 5.Surgical Procedures for Preventing Urological Complications Following Radical Hysterectomy / M.Matsuzawa et al. / p398~398
  • Workshop 8 6.Surgical Chemotherapy for Advanced Uterine Cervival Cancer / M.Iwasaki et al. / p398~398
  • Workshop 8 7.Combination Therapy with Radical Hysterectomy in Cancer of Uterine Cervix / H.Noguchi / p399~399
  • Workshop 8 8.The Effects of Reduction Surgery and Chemotherapy on Patients with Advanced Ovarian Cancer / M.Yasuda et al. / p399~399
  • Workshop 9 Multimodulated Therapy Combined with Surgery--Skin,Bone and Soft Tissue / / p400~406
  • Workshop 9 1.Surgical and Combined Treatment of Malignant Melanoma / K.Ishihara et al. / p400~400
  • Workshop 9 2.Primary Malignant Melanoma of the Head and Neck--An Experience of 11 Cases / K.Omura et al. / p400~400
  • Workshop 9 3.Practical Multidisciplinary Therapy for Skin Squamous Cell Carcinoma,Incorporating Peplomycin(PEP)and Bestatin / H.Miyasato et al. / p401~401
  • Workshop 9 4.Laser Surgery of Carcinoma of the Skin / K.Hishimoto et al. / p401~401
  • Workshop 9 5.Adriamycin Ointment for Treatment of Recurrent Carcinoma / M.Fukuda et al. / p402~402
  • Workshop 9 6.Three Cases of Ectopic Breast Carcinoma / M.Ishigaki et al. / p402~402
  • Workshop 9 7.Prognostic Factors in Osteosarcoma / K.Furuse et al. / p403~403
  • Workshop 9 8.En Bloc Resection for Osteosarcoma / N.Matsui et al. / p403~403
  • Workshop 9 9.The Studies on the Wide Resection for Limb Preservation Combined with Pre-operative Intra-arterial Infusion of Anti-cancer Agents in Osteosarcoma / S.Takeuchi et al. / p404~404
  • Workshop 9 10.Clinical Study of Limb Saving Operation for Osteosarcoma / S.Higaki et al. / p404~404
  • Workshop 9 11.Surgery,Radiotherapy and Chemotherapy for Ewing's Sarcoma / S.Takeyama et al. / p405~405
  • Workshop 9 12.Malignant Giant Cell Tumor of Bone / S.Toriyama et al. / p405~405
  • Workshop 9 13.Six Cases of Malignant Giant-cell Tumor of Bone / S.Yamawaki et al. / p406~406
  • Workshop 10 Radiation Therapy / / p407~414
  • Workshop 10 1.Precision Radiation Treatment Planning System (Application of CT to Radiation Treatment Planning System) / T.Iwata et al. / p407~407
  • Workshop 10 2.Radiotherapy Planning with CT Scan for Prostatic Carcinoma / K.Hayakawa et al. / p407~407
  • Workshop 10 3.Application in Computer Reconstruction Technique for Conformation Radiotherapy Planning / T.Ishigaki / p408~408
  • Workshop 10 4.Precision Conformation Radiotherapy Using the Modified,Multileaved Collimators / Y.Tanaka et al. / p408~408
  • Workshop 10 5.Radiation Therapy for the Local Recurrence of Breast Carcinoma and the Effect of Chest Wall Lymphatic Drainage / S.Matsubara et al. / p409~409
  • Workshop 10 6.Tissue Tolerance Limit of Radiotherapy for Carcinoma of the Oral Cavity and Treatment of Radiation Injuries / M.Nakano et al. / p409~409
  • Workshop 10 7.Afterloading Small Source Irradiation Technique for Lesions in Deep-seated Organs / M.Kakehi / p410~410
  • Workshop 10 8.Clinical Experience with Fast Neutron Therapy Utilizing High Intensity Californium-252 Sources / T.Dokiya et al. / p410~410
  • Workshop 10 9.Inhibition of Potentially Lethal Damage(PLD)Repair: Its Implication in Radioresistant Tumor Therapy / S.Nakatsugawa et al. / p411~411
  • Workshop 10 10.Experience of Radiotherapy Combined with Hypoxic Cell Radiosensitizer,Misonidazole / K.Ono et al. / p411~411
  • Workshop 10 11.Combined Chemoradiotherapy for Malignant Brain Tumors / H.Yamamoto et al. / p412~412
  • Workshop 10 12.Several Fractionation Protocols in Case of Combined Radiotherapy with Polychemotherapy / H.Asakura et al. / p412~412
  • Workshop 10 13.Studies on Immunological Parameters in the Cancer Patients under Chemotherapy and Immunotherapy Report5: T and B Cells and Lymphoblastogenesis / T.Komita et al. / p413~413
  • Workshop 10 14.An Opinion of Preoperative Irradiations for the Advanced Cancers / S.Mikuriya et al. / p413~413
  • Workshop 10 15.Role of Intravenous Hyperalimentation(IVH)in Radiotherapy of Carcinoma of the Esophagus / M.Takahashi et al. / p414~414
  • Workshop 11 Immunotherapy / / p415~424
  • Workshop 11 1.Effect of C.Parvum and Poly ICLC on Experimentary Brain Tumor--Comparison between Local Administration and General Administration / K.Kiya et al. / p415~415
  • Workshop 11 2.Post-operative Immunotherapy with OK-432 for Oral Cancer Patients / H.Adachi et al. / p415~415
  • Workshop 11 3.Immunological Treatment of the Head and Neck Cancer / E.Yamamoto et al. / p416~416
  • Workshop 11 4.Evaluation of Multidisciplinary Treatments Against Bladder Cancer II. Variations of Non-specific Immunoparameters in Maintenance Therapy(P.S.K.+CQ) / Y.Nakagami et al. / p416~416
  • Workshop 11 5.The Prognosis of the Uterine Cervical Cancer Patients Treated by Radiotherapy Combined with PSK / T.Kasamatsu et al. / p417~417
  • Workshop 11 6.The Pitfall of Immunotherapy in Children with All / H.Akane et al. / p417~417
  • Workshop 11 7.Successful Remission Maintenance Immunotherapy by OK-432 in Malignant Lymphoma / S.Shirakawa et al. / p418~418
  • Workshop 11 8.Immunotherapy of Hematological Malignancies with Krestin / T.Nagao et al. / p418~418
  • Workshop 11 9.Serological Analysis of Melanoma Patients Immunized with Autologous Melanoma Cells / T.Watanabe et al. / p419~419
  • Workshop 11 10.Serum Immunosuppressive Factors as Parameters of Cell-mediated Immunity in Cancer Patients during Immunotherapy / K.Ishitani et al. / p419~419
  • Workshop 11 11.A New Protocol of Passive Immunotherapy with Tumor Specific Immune RNA / M.Fukushima et al. / p420~420
  • Workshop 11 12.Combination Chemoimmunotherapy for Gastric Carcinoma / M.Kawaguchi et al. / p420~420
  • Workshop 11 13.A Large Dose of OK-432 Immunotherapy in Gastric Cancer Patients Undergoing Absolute Non Curative Resection / T.Toge et al. / p421~421
  • Workshop 11 14.Preoperative Local Immunotherapy Immunomorphological Evaluation of Host Response at Primary Gastric Carcinomas and Their Regional Lymph Nodes Induced by Intratumoral Injection of OK-432 / Y.Kodama et al. / p421~421
  • Workshop 11 15.Immunotherapy with OK-432,Streptococcus Pyogens Preparation,for Cancer Patients--Correlations between the Change of Immunological Response and the Survival Period / H.Hanaue et al. / p422~422
  • Workshop 11 16.Study of the Immune Response in the Cancer Patients by the Longterm Intravenous Administration of OK-432 / A.Kawamura et al. / p422~422
  • Workshop 11 17.The Study on Intraarterial Immunochemotherapy Using Lentinan / M.Ryu et al. / p423~423
  • Workshop 11 18.Effects on Tumor Growth of Various Immunopotentiators in Splenectomized Tumor-bearing Rats Experimental Study Using a Rat's Mammary Tumor,MRMT-1 / S.Saji et al. / p423~423
  • Workshop 11 19.Splenectomy and Immunotherapy for the Treatment of Advanced Gastric Cancer / H.Miwa et al. / p424~424
  • Workshop 11 20.Pitfall of Immunotherapy of Inoperable Advanced Gastric Cancer--With Special References of Induction of Suppressor T Cells / S.Koyama et al. / p424~424
  • Workshop 12 Malignant Tumors in Childhood / / p425~428
  • Workshop 12 1.Pitfalls in Diagnosis of Neuroblastoma and in Treatment of Wilms'Tumor / H.Tsunooka et al. / p425~425
  • Workshop 12 2.Critical Evaluation of Urinary Vanilmandelic Acid(VMA)and Homovanillic Acid(HVA)as Tumor Markers for Neuroblastoma / K.Yokomori et al. / p425~425
  • Workshop 12 3.Results of Surgical Treatment with Adjuvant Chemotherapy for Advanced Neuroblastoma (Stage III&IV) / S.Ogita et al. / p426~426
  • Workshop 12 4.Rapid Growth of Metastatic Tumors after Second-look Operation among Patients with Advanced Neuroblastoma / T.Matsuda et al. / p426~426
  • Workshop 12 5.Treatment of Advanced Abdominal Neuroblastoma--Significance of Metastatic Lymph Nodes for Recurrence / J.Uchino et al. / p427~427
  • Workshop 12 6.A Problem on Radiotherapy for Pulmonary Metastases of Wilms'Tumor / N.Ohnuma et al. / p427~427
  • Workshop 12 7.Not Received / /
  • Workshop 12 8.Late Manifestation of Occult Blood Born Metastases / K.Nagashima et al. / p428~428
  • General Lecture 1.Changes in Cystoscopical Growth Pattern of Recurrent Bladder Tumors / T.Takesue et al. / p429~429
  • General Lecture 2.Growth Kinetics of Human Gastric and Colon Carcinoma Transplanted in the Nude Mice / K.Bando et al. / p429~429
  • General Lecture 3.Correlations between Preoperative Administration of Anti-cancer Agents against Human Digestive Organ Cancers and Its Transplantability to Nude Mice / E.Kawamura et al. / p430~430
  • General Lecture 4.Heterotransplantation of the Human Carcinomas into Nude Mice / K.Sakuramoto et al. / p430~430
  • General Lecture 5.Cell Surface Antigens of Human Melanoma Detected by Monoclonal Antibody / K.Nishiyama et al. / p431~431
  • General Lecture 6.The Specific Red Cell Adherence Test and Bladder Cancer / H.Takigawa et al. / p431~431
  • General Lecture 7.Inhibition of Tumor Cells and Platelets in Formation of Tumor Thrombs / T.Ishii et al. / p432~432
  • General Lecture 8.Local Fibrinolytic Activity and Inhibitory Activity of Human G-I Tract Cancer Tissues--Comparison between Esophageal,Gastric and Colon Cancers / M.Sato et al. / p432~432
  • General Lecture 9.A Study of Granulocytosis in a Patient of Primary Pancreatic Carcinoma / T.Ishii et al. / p433~433
  • General Lecture 10.Transitory Reduction of Blood Pressure Due to Metastatic Cervical Node Cancer / S.Takoda et al. / p433~433
  • General Lecture 11.Impaired Glucose Metabolism and Its Related Hormone Environment in Endometrial Cancer / K.Kuzuya et al. / p434~434
  • General Lecture 12.Studies on the Concomitant Infections in Cancer Patients Treated in Our Clinic / S.Okubo et al. / p434~434
  • General Lecture 13.Index of Immunological and Nutritional Status in Cancer Patients (Cancerous Cachexy Index:CCI) / M.Sato et al. / p435~435
  • General Lecture 14.Postoperative Death of Gastric Cancer Patients,with Special Reference to the Surgery-associated Death and Multiple Organ Failure / T.Nakajima et al. / p435~435
  • General Lecture 15.Experimental Studies Concerning the Antitumor Effect in the Lymph Node of Tumor Bearing Host / H.Matsumoto et al. / p436~436
  • General Lecture 16.Effects of Adult Thymectomy on the Growth of 203-glioma in Mice / T.Yamasaki et al. / p436~436
  • General Lecture 17.Studies on Thymus Lymphocytes from Rat with BBN Induced Bladder Tumor(First Report)Effect of Calf Thymus Humoral Factor on In Vitro Con A Response of Thymus Lymphocytes / S.Wada et al. / p437~437
  • General Lecture 18.Stimulatory Effect of 2-mercaptoethanol on Tumor Bearers with Suppressed Immune Status and Its Therapeutic Effect / Y.Kikuchi et al. / p437~437
  • General Lecture 19.Effects on Tumor Metastasis of Operative Stress by Tumor Excision and Laparotomy Experimental Analysis Using a Rat's Mammary Tumor,MRMT-1 / T.Takekoshi et al. / p438~438
  • General Lecture 20.Immunological Function and Effect of Chemotherapy in Protein-Calorie Deficient Mice / M.Akimoto et al. / p438~438
  • General Lecture 21.Specific Cell-mediated Immunity in Patients with Cervical Cancer / H.Mori et al. / p439~439
  • General Lecture 22.Induction of Specific Immune Lymphocytes against Autologus Tumor Cells / H.Kimura et al. / p439~439
  • General Lecture 23.On Clinical Features of the Cases in which Cytotoxicity was Evidenced with Mixed Lymphocyte-autotumor Cell Culture / S.Yamamoto et al. / p440~440
  • General Lecture 24.Evaluation of Specific S.I. in Patients with Bladder Carcinoma / S.Nishio et al. / p440~440
  • General Lecture 25.Effect of Surgery on Cell-mediated Immunity in Cancer Patients / S.Miyazaki et al. / p441~441
  • General Lecture 26.Not Received / /
  • General Lecture 27.Natural Killer Activity in Intracranial Tumor Bearing Mice and Patients with Brain Tumors / S.Otsuka et al. / p441~441
  • General Lecture 28.Distribution of Natural Killer Activity in Gastric Cancer Patients / Y.Moritani et al. / p442~442
  • General Lecture 29.A Study on Natural Killer Cell Activity in the Patients with Cancer of Digestive Tract / H.Matsumoto et al. / p442~442
  • General Lecture 30.Studies on Natural Killer Activity in Cancer Patients / K.Senba et al. / p443~443
  • General Lecture 31.Dissociation of Natural Killer Activity and Affinity of Subpopulations of Peripheral Lymphocytes in Cancer Patients and Normal Donors / T.Matsui et al. / p443~443
  • General Lecture 32.Prognostic Value of NK Activity and ADCC in Tumor-bearing Patients / N.Irimajiri et al. / p444~444
  • General Lecture 33.Study on the Changes of Immune Reactivities during Maintenance Therapy for Uterine Cancer / T.Kanda et al. / p444~444
  • General Lecture 34.Changes of Immune Status of Breast Carcinoma Patients after the Topical Administration of Emulsionized 5-fluorouracil (5-Fu) / G.Katsuki et al. / p445~445
  • General Lecture 35.Immune Status of Breast Cancer Patients before and after Operation / Y.Haga et al. / p445~445
  • General Lecture 36.Cell-mediated Immunological Dynamics after Operation about the Patients with the Gastric Cancer / Y.Fuyuhiro et al. / p446~446
  • General Lecture 37.The Postoperative Immunity in the Gastric Cancer,and Its Change with the Anti Cancer Agents Administration / K.Ishiyama et al. / p446~446
  • General Lecture 38.All-round Estimation of Cellular Immunity of Cancer Patients and of Effectiveness of Immunopotentiators by Using of Several Routine Parameters of Lymphocytes / T.Shimbo et al. / p447~447
  • General Lecture 39.As for the Dynamics of Peripheral Eosinocytes in Patients with Gastric Cancer / T.Fujii et al. / p447~447
  • General Lecture 40.Peripheral Blood Monocyte Count & Monocyte Function in Gastric Cancer Patient / T.Yamane et al. / p448~448
  • General Lecture 41.Skin Reactivity to PHA and PPD in Sick and Healthy Persons / S.Shimada et al. / p448~448
  • General Lecture 42.Correlations between Renal Carcinoma Patients and PPD,PHA Skin Test / M.Hata et al. / p449~449
  • General Lecture 43.Effect of Lung Cancer Operations on Postoperative Cellular Immunity / T.Sakai et al. / p449~449
  • General Lecture 44.Comparative Study of Immune Competence of Breast Cancer Patients between in Positive Estrogen Receptor Cases and in Negative Cases / A.Kimoto et al. / p450~450
  • General Lecture 45.Immunological Behavior and Prognosis of Patients with Cancer of the Head and Neck / K.Fujii et al. / p450~450
  • General Lecture 46.Not Received / /
  • General Lecture 47.General Immunocompetence in Gastric and Colorectal Cancer Patients / E.Yasui et al. / p451~451
  • General Lecture 48.Not Received / /
  • General Lecture 49.The Significance of Human T Cells Bearing IgG-Fc Receptor in the Patients with Bladder Tumor / T.Fujiwara et al. / p451~451
  • General Lecture 50.Changes of ADCC Activity,IgG Fc R⁺T-cell(Tγ)and T,B Subpopulation of Invasive Cervical Cancer Patients during Treatment with or without OK-432 / M.Hatae et al. / p452~452
  • General Lecture 51.Immunosuppressive Acidic Protein in Patients with Head and Neck Cancer / A.Kida et al. / p452~452
  • General Lecture 52.The Clinical Significance of Serum Immunosuppressive Acidic Protein in the Patients of Recurrent Gastric Cancer / S.Kikuchi et al. / p453~453
  • General Lecture 53.Immunosuppressive Acidic Protein (IAP) in Biliary Tract and Pancreatic Cancer Patients / Y.Osaki et al. / p453~453
  • General Lecture 54.Serum Levels of Immunosuppressive Acidic Protein in Patients with Cervical Cancer / S.Shiraki et al. / p454~454
  • General Lecture 55.The Relationship between the Serum Level of Immunosuppressive Acidic Protein and Clinical Status of Gynecologic Malignancies / T.Saito et al. / p454~454
  • General Lecture 56.Significance of Immunosuppressive Acidic Protein (IAP) Measurement on the Gynecologic Malignancies / M.Takeda / p455~455
  • General Lecture 57.Serum Levels of an Immunosuppressive Acidic Protein in Patients with Gynecological Cancer / H.Suzuki et al. / p455~455
  • General Lecture 58.Study of Serum Inhibitory Factor in Patients with Head and Neck Malignancy / K.Sakaguchi et al. / p456~456
  • General Lecture 59.Tumor Immunity in Thyroid Carcinoma: Correlation between Immunosuppressive Substance (ISS) and Anti-thyroid Antibody / A.Sugenoya et al. / p456~456
  • General Lecture 60.Studies on Humoral Immunoregulatory Factors in Gastric Cancer Patients / K.Nakanishi et al. / p457~457
  • General Lecture 61.Immunosuppressive Substance (ISS) in the Serum of Patients with Colonic Cancer / S.Fuchimoto et al. / p457~457
  • General Lecture 62.Immune Response Suppression by Ascitic Fluid of Patient with Gastrointestinal Cancer / K.Amemiya et al. / p458~458
  • General Lecture 63.Recurrent Breast Cancer Treated with Chest Wall Reconstruction after Local Excision / Y.Uyama et al. / p458~458
  • General Lecture 64.Pathologic Identification of Breast Cancer Patients with High Risk of Recurrence after Radical Mastectomy / T.Nakamura et al. / p459~459
  • General Lecture 65.A Study of the Postoperative Recurrent Cases of Breast Cancer / T.Asagoe et al. / p459~459
  • General Lecture 66.Study of Therapeutic Result for Local Breast Cancer / H.Yamashita et al. / p460~460
  • General Lecture 67.The Analysis of the Causes of Death more than 5 Years after Mastectomy and Treatment of Recurrence or Metastasis from Breast Cancer / T.Sakurai et al. / p460~460
  • General Lecture 68.The Correlation between the Incidences of Lymphatic Metastases and the Sites of Tumors / T.Kusano et al. / p461~461
  • General Lecture 69.Prognosis of 81 Patients Operated Curatively for n₂(+)Gastric Cancer / K.Azekura et al. / p461~461
  • General Lecture 70.The Prognosis of Early Gastric Cancer in the Middle Third of Stomach and Their Lymph Nodes Metastasis at Operation / H.Furukawa et al. / p462~462
  • General Lecture 71.A Study of Early Gastric Cancer--Specially Centered to Lymph Node Metastases / A.Misao et al. / p462~462
  • General Lecture 72.Leukemoid Reaction and Bone Marrow Metastasis of the Gastric Cancer / S.Harashima et al. / p463~463
  • General Lecture 73.Clinical and Statistical Study of Factors Affecting Prognosis in Esophageal Cancer / Y.Arai et al. / p463~463
  • General Lecture 74.Postoperative Prognosis of the Esophageal Cancer with No Lymphatic Involvement / Y.Sannohe et al. / p464~464
  • General Lecture 75.Histologic Characteristics of a Small Carcinoma of the Stomach with Hepatic Metastasis / O.Kimura et al. / p464~464
  • General Lecture 76.Histologic Characteristics of Early Recurrent Cases of Gastric Cancer after Curative Gastrectomy / H.Nishidoi et al. / p465~465
  • General Lecture 77.Natural Time History of Endometrial Cancer / R.Tsunematsu et al. / p465~465
  • General Lecture 78.Statistical and Immunological Studies on Recurrent Cancer of the Uterine Cervix / S.Katashima et al. / p466~466
  • General Lecture 79.A Study on Risk Factors Concerned with Lymph Node Metastasis of Uterine Cervical Cancer / Y.Tsukahara et al. / p466~466
  • General Lecture 80.Lymphography and Prognosis of Cervical Cancer Clinical Value of Unusual Opacification of Mediastinal,Cervical and Axillar Lymphnodes / J.Ito et al. / p467~467
  • General Lecture 81.A Case of Uterine Cervical Carcinoma who Had Wide-spread Bony Metastases / T.Kotani et al. / p467~467
  • General Lecture 82.A Case of Stage Ia Carcinoma of the Uterine Cervix with Lymph Node Metastasis / Y.Kato et al. / p468~468
  • General Lecture 83.Metastasis of Transitional Cell Carcinoma of the Upper Urinary Tract / G.Nakada et al. / p468~468
  • General Lecture 84.Examination on Post-operative Metastasis of Bladder Cancer / K.Numasawa et al. / p469~469
  • General Lecture 85.Analysis of 57 Autopsy Cases of Bladder Cancer / K.Tashiro et al. / p469~469
  • General Lecture 86.Clinical Evaluation of the Treatment for Disseminated Testis Tumor--Combined Modality of Chemotherapy and Cytoreductive Surgery / T.Tsukamoto et al. / p470~470
  • General Lecture 87.Combined Therapy for Metastatic Lung Cancer from the Testicular Tumor / S.Mikuriya et al. / p470~470
  • General Lecture 88.Prognostic Analysis of Malignant Pleural and Peritoneal Effusions / S.Yamada et al. / p471~471
  • General Lecture 89.Malignant Pericarditis by Bronchogenic Carcinoma / T.Shinkai et al. / p471~471
  • General Lecture 90.A Trial of Combined Modality Therapy for Malignant Pericarditis / K.Okabe et al. / p472~472
  • General Lecture 91.Studies on the Gastric Cancer Patients with Intraperitoneal Free Cancer Cells / Y.Iitsuka et al. / p472~472
  • General Lecture 92.Cytology,Colposcopy and Colposcopic Target Biopsy to the Early Diagnosis of the Uterine Cervical Cancer--The Correlation between These Diagnostic Methods and the Final Diagnosis / S.Yoh et al. / p473~473
  • General Lecture 93.Studies on Preoperative Diagnosis of Early Cervical Carcinoma--Concerning Reduction of Diagnostic Cone Biopsy / T.Horii et al. / p473~473
  • General Lecture 94.Needle Aspiration Cytology in Diagnosis of Breast Tumors / F.Nagata et al. / p474~474
  • General Lecture 95.Aspiration Cytology in the Diagnosis of Breast Cancer with Special Regard to the Influence upon Prognosis / Y.Nishizawa et al. / p474~474
  • General Lecture 96.Urinary Cytology in Patients with Urothelial Tumor / K.Suzuki et al. / p475~475
  • General Lecture 97.Cytological Screening of Urinary Tract Cancer in Combination with Routine Urinalysis / R.Abe et al. / p475~475
  • General Lecture 98.Vascular Involvement in Mainly T₁ Carcinoma of the Tongue / T.Matsushima et al. / p476~476
  • General Lecture 99.The Fine Angioarchitecture of Corpus Uteri / Y.Nakagiri et al. / p476~476
  • General Lecture 100.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases (VII) -On Local Lymphocyte Infiltration and Immunological Alteration of Long Survival Cases of Cancer Patients- / S.Nakagawa et al. / p477~477
  • General Lecture 101.T Lymphocytes in Cancer Tissues of the Head and Neck Regions An Immunohistochemical Investigation / T.Furusaka et al. / p477~477
  • General Lecture 102.Stromal Reaction in Bladder Tumor (4th Report) -The Role of Local Lymph Follicles and Immunoblastoid Cells- / R.Yasumoto et al. / p478~478
  • General Lecture 103.A Study on Perifocal Stroma in Cervical Cancer / T.Sano et al. / p478~478
  • General Lecture 104.Cytohistochemical Studies on the Estrogen Receptor of Mammary Tissues in Mammary Carcinoma and Other Diseases by the Immunoperoxidase Method / K.Matsumoto et al. / p479~479
  • General Lecture 105.Histochemical Study on Androgen Binding Protein of Cancerous Prostate / T.Matsumura et al. / p479~479
  • General Lecture 106.Immunohistochemical Localization of Prostatic Acid Phosphatase(P.A.P.)in Prostatic Cancer / K.Endo et al. / p480~480
  • General Lecture 107.Polyamine Levels in Tissues of Colorectal Carcinoma / J.Miyata et al. / p480~480
  • General Lecture 108.A Comparative Study of Histochemical Patterns of CEA and Mucins in Gastric Cancer / T.Tanioku et al. / p481~481
  • General Lecture 109.Tissue Carcinoembryonic Antigen in Colorectal Cancer / H.Tomoda et al. / p481~481
  • General Lecture 110.Immuno Histological Staining of Tumor Marker and Correlations between Tissue Level and Serum Level of CEA in Resectable and Unresectable Pancreatic Cancer Patients / T.Amemiya et al. / p482~482
  • General Lecture 111.Tissue Localization of Immunoglobulin,Carcinoembryonic Antigen(CEA)and Human Chorionic Gonadotropin(HCG)in Carcinoma of the Uterine Cervix / M.Kawamoto et al. / p482~482
  • General Lecture 112.Clinical Studies of Carcinofetal Proteins in Carcinoma of the Uterine Cervix Immunohistochemically / N.Kadomoto et al. / p483~483
  • General Lecture 113.Follow-up Study of the Leukoplakia of the Oral Cavity / A.Inoue et al. / p483~483
  • General Lecture 114.Studies on Surface Roughness of Carcinoma of the Oral Mucosa / T.Amagasa et al. / p484~484
  • General Lecture 115.The Clinical Features of Minute and Small Thyroid Carcinoma / N.Kasai et al. / p484~484
  • General Lecture 116.Statistical Studies on Registrated Thyroid Cancer Patients in Japan / S.Ebihara et al. / p485~485
  • General Lecture 117.Statistical Evaluation of Neck Masses--Evaluation of Ultrasonography in Differential Diagnosis of Neck Masses / M.Miyata et al. / p485~485
  • General Lecture 118.Cervical Tumors / K.Furukawa et al. / p486~486
  • General Lecture 119.Facial Nerve Paralysis in Parotid Gland Tumors / T.Kato et al. / p486~486
  • General Lecture 120.A Clinicopathologic Study on the Patient Survived more than 10 Years after Operation for Advanced Gastric Cancer / A.Sakuma et al. / p487~487
  • General Lecture 121.Clinicopathological Analysis of Early Gastric Carcinoma--An Analysis of 217 Cases / M.Sowa et al. / p487~487
  • General Lecture 122.A Study on Cancer of Large Bowel in the Early Stage / A.Sato et al. / p488~488
  • General Lecture 123.A Clinicopathological Study of Fourteen Cases with Perforated Gastric Cancer / S.Kondo et al. / p488~488
  • General Lecture 124.Not Received / /
  • General Lecture 125.Clinical Studies on the Prognosis of Non-resectable Gastric Cancer / H.Oshibuchi et al. / p489~489
  • General Lecture 126.Clinicopathological Study on Palliative Resection of Colorectal Carcinoma / S.Tabuchi et al. / p489~489
  • General Lecture 127.Histo-pathology and Clinical Study on Stage"Shallow Ib"Carcinoma of Uterine Cervix / K.Taoka et al. / p490~490
  • General Lecture 128.The Significances of Histological Typing for Cervical Carcinoma / T.Inoue et al. / p490~490
  • General Lecture 129.A Clinicopathologic Study for 9 Patients with Extramammary Paget's Disease of the Vulva / S.Kodama et al. / p491~491
  • General Lecture 130.A Pathological Study of the Correlation between Mitotic Count and the Prognosis of Ovarian Cancer / H.Nishimura et al. / p491~491
  • General Lecture 131.Not Received / /
  • General Lecture 132.Clinical and Pathological Analysis of Germ Cell Tumors of the Ovary / T.Miyazaki et al. / p492~492
  • General Lecture 133.Studies on Bladder Tumor in 36 Cases less than 40 Years Old / T.Tochigi et al. / p492~492
  • General Lecture 134.Clinical Analysis of the Bladder Tumor according to General Rule on Bladder Cancer / K.Okada et al. / p493~493
  • General Lecture 135.Clinical Analysis of 155 Bladder Cancer Patients with Special Reference to the Prophylactic Instillation Therapy / T.Misaki et al. / p493~493
  • General Lecture 136.Clinico-pathological Study of Renal Cell Carcinoma / T.Murase et al. / p494~494
  • General Lecture 137.Not Received / /
  • General Lecture 138.Not Received / /
  • General Lecture 139.Malignant Schwannoma with Prolonged Fever,Anemia and Hypergammaglobulinemia / K.Hashimoto et al. / p494~494
  • General Lecture 140.Pediatric Malignancies in the Head and Neck / M.Horiuchi et al. / p495~495
  • General Lecture 141.Treatment for Liver Cell Carcinoma in Infants and Children--In Special Reference to Histological Problems / A.Toyosaka et al. / p495~495
  • General Lecture 142.The Mass Screening Campaign for Breast Cancer in Kanagawa Prefecture(The Second Report) / N.Tamura et al. / p496~496
  • General Lecture 143.Mass Screening for Breast Cancer / Y.Nakano et al. / p496~496
  • General Lecture 144.Mass Screening of Breast Cancer in Miyagi Prefecture / R.Abe et al. / p497~497
  • General Lecture 145.Not Received / /
  • General Lecture 146.11 Years Experience with Mass Screening for Breast Cancer in Tokushima Prefecture / F.Nishiyama et al. / p497~497
  • General Lecture 147.Experience of Mass Screening of Neuroblastoma in Infants / H.Tsunooka et al. / p498~498
  • General Lecture 148.Mass Screening for Colorectal Cancer Using Fecal Occult Blood Testing / M.Fujita et al. / p498~498
  • General Lecture 149.The Result of Mass Screening for Cervical Cancer in Miyagi Prefecture / S.Sato et al. / p499~499
  • General Lecture 150.The Present Status and Problems Relative to Group Examinations for Uterine Cervix Cancer in Fukushima Prefecture / K.Niitsuma et al. / p499~499
  • General Lecture 151.Report of 15 Multiple Primary Cancers in Our Department / H.Kamata et al. / p500~500
  • General Lecture 152.Diagnosis,Treatment and Prognosis of Double Primary Cancers / S.Tanimura et al. / p500~500
  • General Lecture 153.Study of Double Primary Malignant Neoplasm in Our Clinic / M.Kita et al. / p501~501
  • General Lecture 154.Multiple Primary Carcinomas of Esophagus and Other Organs / H.Shibuya et al. / p501~501
  • General Lecture 155.Clinical Study of Primary Multiple Cancers / M.Furukawa et al. / p502~502
  • General Lecture 156.Application of Low Cytometry to the Evaluation of the Effect by Chemotherapy in Gynecological Malignancies / M.Sugita et al. / p502~502
  • General Lecture 157.Study on High Risk Cases of Cervical Carcinoma after Treatment Assessed by Prospective Analysis / T.Maeda et al. / p503~503
  • General Lecture 158.Scale Transformation for Analysis of Cancer Survival Curves / S.Maetani et al. / p503~503
  • General Lecture 159.Analysis of the Prognostic Factors for Non-Hodgkin's Lymphoma by the Cox Regression Life Table Method / K.Tajima et al. / p504~504
  • General Lecture 160.Management of Data on Treating Cancer Patients Utilizing Microcomputer / K.Kaneta et al. / p504~504
  • General Lecture 161.Multi-image Diagnosis in Thyroid Tumors / Y.Takahashi et al. / p505~505
  • General Lecture 162.Clinical and Experimental Studies on the Diagnostic Methods of the Breast Diseases--With Special References to the Score System / A.Nakano et al. / p505~505
  • General Lecture 163.The Significance of the Ultrasonography and the Deep Body Thermometer as a Supplementary Diagnostic Method for the Breast Cancer / K.Tohyama et al. / p506~506
  • General Lecture 164.About Ultrasonography of the Breast Tumor / K.Nagano et al. / p506~506
  • General Lecture 165.The Use of Echolaparoscope on the Diagnosis of Hepatobiliary Malignancies / M.Fukuda et al. / p507~507
  • General Lecture 166.Diagnostic Tomography for Prostatic Carcinoma / Y.Sawamura et al. / p507~507
  • General Lecture 167.Follow-up Study of NPC Cases Using Computed Tomography / K.Harada et al. / p508~508
  • General Lecture 168.Evaluation of CT Diagnosis for the Extent of Primary Lung Cancer / T.Yusa et al. / p508~508
  • General Lecture 169.Hepatic Artery Occlusion (Transcatheter Embolization and Ligation) in Hepatomas,Assessed by Computed Tomography and α-fetoprotein Value in the Serum Following Angiography / T.Sugiu et al. / p509~509
  • General Lecture 170.Not Received / /
  • General Lecture 171.Screening Use for Detecting Lymphnodes Metastasis of Cervical Cancer by Using Radio-isotope(RI) Lymphography / T.Fujita et al. / p509~509
  • General Lecture 172.Lymphography and Lymphoscintigraphy in Urogenital Cancers / N.Saito et al. / p510~510
  • General Lecture 173.Local Findings of Renal Cell Carcinoma on Scintigraphic Modalities / J.Kawamura et al. / p510~510
  • General Lecture 174.Measurement of Regional Effective Hepatic Blood Flow Using¹⁹⁸Au-colloid / H.Mimura / p511~511
  • General Lecture 175.Estimation of Clinical Efficacy for Scintigraphic Images of Liver / K.Machida et al. / p511~511
  • General Lecture 176.Significance of Microcalcification on Mammographic Diagnosis of Early Breast Cancer / T.Ohashi et al. / p512~512
  • General Lecture 177.Not Received / /
  • General Lecture 178.Effect of Combined Bleomycin Mitomycin C Chemotherapy for Lung Metastasis of Cervical Cancer Evaluated by Tumor Volume Ratio / Y.Matsuura et al. / p521~512
  • General Lecture 179.Usefulness of Pyeloureteroscopy(Ureterorenoscopy)in the Diagnosis of Malignant Tumors of the Upper Urinary Tract / Y.Aso et al. / p513~513
  • General Lecture 180.Role of Serum Markers(Human Chorionic Gonadotropin and Alpha-fetoprotein)in the Manage-ment of Testicular Germ Cell Tumors / M.Hagiwara et al. / p513~513
  • General Lecture 181.Urinary HCG of Patients with Malignant Tumors Treated with Radiotherapy / T.Nakano et al. / p514~514
  • General Lecture 182.Sequential Assay System of hCG Including hCG-β C-Terminal Peptide(hCG-βCTP)Assay for the Management of Trophoblastic Diseases / Y.Ashitaka et al. / p514~514
  • General Lecture 183.Characteristics of Anti-hCGβ-Carboxyl-Terminal Peptide Sera and Its Application in the Clinical Management of Trophoblastic Diseases / S.Matsuura et al. / p515~515
  • General Lecture 184.Ectopic Alpha Subunit of Human Chorionic Gonadotropin Producing Tumor / N.Morimoto et al. / p515~515
  • General Lecture 185.Studies on CEA in Tissue and Blood, Relating to Diagnosis, Therapeutic Effect and Prognostic Prediction in Ovarian Cancer / T.Oosaki et al. / p516~516
  • General Lecture 186.Clinical Evaluation of Serum CEA Levels in Uterine Cervix Cancer with Radiotherapy / Y.Kikuchi et al. / p516~516
  • General Lecture 187.Correlations between Serum Glycoprotein and Carcinoembryonic Antigen(CEA)in Patients with Gastric Cancer / K.Morita et al. / p517~517
  • General Lecture 188.The Usefulness of the Changing Rate of Serum Carcinoembryonic Antigen(CEA)during Anticancer Therapy of the Pancreatic Carcinoma / O.Ishikawa et al. / p517~517
  • General Lecture 189.Clinical Meanings of CEA in the Treatment of Cancer of Large Intestine / S.Takashima et al. / p518~518
  • General Lecture 190.Serum Ferritin Levels in Gynecologic Malignant Diseases / T.Arai et al. / p518~518
  • General Lecture 191.Tumor Markers in Renal Cancer Patients / H.Hisazumi et al. / p519~519
  • General Lecture 192.A Clinical Evaluation of Serum Ferritin as a Tumor Marker of Lung Cancer / Y.Ariyoshi et al. / p519~519
  • General Lecture 193.Markers in Hormone Dependent Tumors (I.Thyroid and Breast Cancers) / T.Tabei et al. / p520~520
  • General Lecture 194.The Amount of Concanavalin A Non-reactive Alpha-fetoprotein in Yolk Sac Tumor and Other Hepatic Lesions / Y.Tsuchida et al. / p520~520
  • General Lecture 195.Urinary Hydroxyproline Excretion as a Marker of Bone Metastases in Prostatic Cancer` / K.Rinsho et al. / p521~521
  • General Lecture 196.Clinical Studies on Radioimmunoassay of Prostatic Acid Phosphatase / Y.Ohmi et al. / p521~521
  • General Lecture 197.Total Sialic Acid and Lipid Bound Sialic Acid in the Sera of Cancer Patients / S.Oki et al. / p522~522
  • General Lecture 198.Diagnosis and Treatment of Head and Neck Cancer Using Urinary Biochemical Markers / T.Hotate et al. / p522~522
  • General Lecture 199.Detection of Liver Metastases with 5'Nucleotide Phosphodiesterase Isoenzyme-V in Human Gastric Cancer / M.Kitajima et al. / p523~523
  • General Lecture 200.Thyroglobulin Measurement with Radioimmunoassay in Plasma of Patients with Various Thyroid Disease: Its Usefulness and Problems in Monitoring the Activity of Thyroid Adenocarcinoma / N.Aoki et al. / p523~523
  • General Lecture 201.Experimental Analysis about the Cause of Increased Serum RNase / C.Fujimori et al. / p524~524
  • General Lecture 202.The Significance of Serum Lysozyme Activity in Patients with Cancer / M.Hakosaki et al. / p524~524
  • General Lecture 203.Clinical Uses of Cisplatin for Gynecological Malignant Tumors / M.Ikeda et al. / p525~525
  • General Lecture 204.Chemotherapy of Malignant Ovarian Tumors--Therapeutic Results of Cisplatin / K.Yamashita et al. / p525~525
  • General Lecture 205.Combination Chemotherapy with Cis-dichlorodiamine Platinum and the Other Agents for Ovarian and Tubal Cancer / M.Fukuoka et al. / p526~526
  • General Lecture 206.Pathologically Followed Anti-cancer Effect of Cis-platinum Based Combined Chemotherapy for Recurrent Ovarian Cancer / H.Fukuoka et al. / p526~526
  • General Lecture 207.Chemotherapy of Ovarian Adenocarcinoma with Cisplatin and Adriamycin / N.Tsukamoto et al. / p527~527
  • General Lecture 208.Phase II Trial with Cisplatin in Ovarian Malignancies / H.Ito et al. / p527~527
  • General Lecture 209.Combination Chemotherapy with Cis-dichlorodiammineplatinum(II)in Disseminated Testicular Cancer / T.Miki et al. / p528~528
  • General Lecture 210.CDDP Combination Chemotherapy for Non-seminomatous Testicular Cancer / Y.Akasaka et al. / p528~528
  • General Lecture 211.The Chemotherapy Using CDDP for Advanced Urogenital Malignancy / K.Miyakoda et al. / p529~529
  • General Lecture 212.Cis-diammine Dichloroplatinum(CDDP)Combination Chemotherapy for Advanced Urogenital Malignancies / G.Hamami et al. / p529~529
  • General Lecture 213.Combination Chemotherapy with Cis-platinum,Ifosfamide and Adriamycin in Patients with Advanced Urogenital Cancer / J.Yoshimoto et al. / p530~530
  • General Lecture 214.A Post Mortem Studied in a Case of Complete Regression Advanced Lung Cancer with Combined MAF Plus Cis-platinum Chemotherapy / T.Tatsumura et al. / p530~530
  • General Lecture 215.Chemotherapy for Squamous Cell Carcinoma--Evaluation of Combination Therapy with Cisplatin and Bleomycin / T.Sasaki et al. / p531~531
  • General Lecture 216.Suppressive Effect of Cis-diamminedichloroplatinum on Natural Killer Cell Activity / T.Hara et al. / p531~531
  • General Lecture 217.Clinical Experience with Cis-diamminedichloroplatinum(II) / M.Suzuki et al. / p532~532
  • General Lecture 218.The Clinical Study of the Cis-platinum(CDDP)on Single-agent or Combination Chemotherapy / T.Goto et al. / p532~532
  • General Lecture 219.Combination Chemotherapy of Cyclophosphamide,Adriamycin and Cis-diamminedichloroplatinum (II) ,CAP Therapy for Advanced Various Malignancies / S.Meguro et al. / p533~533
  • General Lecture 220.Peplomycin for Prostatic Cancer / N.Ohta et al. / p533~533
  • General Lecture 221.Continuous Drip Infusion of Peplomycin in Penile Cancer / T.Obama et al. / p534~534
  • General Lecture 222.Combined Therapy of Esophageal Cancer with Pepleomycin(MK631)and Radiation. / H.Kashimura et al. / p534~534
  • General Lecture 223.Pepleomycin in the Treatment of Refractory Malignant Lymphomas / M.Tanaka et al. / p535~535
  • General Lecture 224.Effect of Pepleomycin(PLM)on Prlmary Lung Cancer and Metastatic Pulmonary Tumor / N.Saijo et al. / p535~535
  • General Lecture 225.A Clinical Trial of a New Mitomycin C Derivative,7-N-(P-hydroxyphenyl)-mitomycinC(KW-2083) / M.Yokoyama et al. / p536~536
  • General Lecture 226,Clinical Study of KW-2083:A Derivative of Mitomycin C / M.Oride et al. / p536~536
  • General Lecture 227.Pilot Study of KW2083 / A.Urata et al. / p537~537
  • General Lecture 228.Clinical Evaluation of KW2083 / I.Nishi et al. / p537~537
  • General Lecture 229.Clinical and Experimental Studies on K-247,a New Synthesized Antitumor Agent / K.ogoshi et al. / p538~538
  • General Lecture 230.Clinical Studies of a New Synthesized Anticancer Agent (K-247) / K.Terabe et al. / p538~538
  • General Lecture 231.Effect of K-247 in Combination with Cancer Immunochemotherapy / T.Mori et al. / p539~539
  • General Lecture 232.Phase II Study of Ethyl(±)-t-6-butoxy-5-fluoro-2,4-dioxohexahydropyrimidine-r-5-carboxylate (TAC-278) / Y.Koyama et al. / p539~539
  • General Lecture 233.A Combination Chemotherapy with ACNU and DTIC for Malignant Melanoma / M.Domyo et al. / p540~540
  • General Lecture 234.Clinical Evaluation of Ifesfamide(Z4942)in Malignant Bone and Soft-tissue Tumors by Multiclinic Co-operative Study / Y.Akahoshi et al. / p540~540
  • General Lecture 235.The Pilot Study of BH-AC as an Adjuvant Chemotherapy / Y.Fujita et al. / p541~541
  • General Lecture 236.Phase II Clinical Study of Vindesine / H.Majima / p541~541
  • General Lecture 237.Preventive Effect of Antihistaminics against Pulmonary Fibrosis with Bleomycin / K.Furushima et al. / p542~542
  • General Lecture 238.Administration of Anticancer Agents in Combination with Hemoperfusion Over Charcoa / J.Yamagata et al. / p542~542
  • General Lecture 239.Efficacy of Kallidinogenase in Combined Chemotherapy for Cancer / A.Uematsu et al. / p543~543
  • General Lecture 240.Studies on the Pharmacodynamics of Tegafur(FutrafulR)Combined with Cytochrome-C / Y.Katsura et al. / p543~543
  • General Lecture 241.Antineoplastic Effect of 5-Fluorocytosine(5-FC)and Cytosine Deaminase (CDase) / T.Nishiyama et al. / p544~544
  • General Lecture 242.Experimental Study of FAM-R Therapy for the Mouse Tumor / K.Okada et al. / p544~544
  • General Lecture 243.Not Received / /
  • General Lecture 244.Experimental Studies on Intraluminal Administration of 5-FU Emulsion as an Adjuvant Chemotherapy to the Surgical Treatment of Gastrointestinal Cancer / K.Yahata et al. / p545~545
  • General Lecture 245.Inhibition of Murine Colon Adenocarcinoma 38 by Indomethacin Treatment / M.Sato et al. / p545~545
  • General Lecture 246.Possible Prevention from the Progression of Cardiotoxicity in Adriamycin-treated Rabbits by Coenzyme Q₁₀ / T.Usui et al. / p546~546
  • General Lecture 247.In vitro and in vivo Evaluation of Antitumer Activity of Aclacinomycin A and Adriamycin against Rat Urinary Bladder Tumor / Y.Kamiryo et al. / p546~546
  • General Lecture 248.Effects of Cis-DDP,Vincristin,and Neocarzinostatin on the Development of Urinary Bladder Tumors Induced by N-Butyl-N(4-Hydroxybutyl)Nitrosamine in Rats / S.Ohara et al. / p547~547
  • General Lecture 249.Continuous Bladder Instillation Therapy of Mitomycin-C on the Transplanted Urinary Bladder Cancer Using Osmotic Mini-pump / H.Akaza et al. / p547~547
  • General Lecture 250.Intravesioal Instillation of Cis-diamminedichloroplatinum (CDDP) / Y.Hirao et al. / p548~548
  • General Lecture 251.Effect of the Combination of Cisplatinum and Peplomycin on Ehrlich Ascites Carcinoma / S.Mashino et al. / p548~548
  • General Lecture 252.Not Received / /
  • General Lecture 253.Pharmacokinetics of 1-hexylcarbamoyl-5-fluorouracil (HCFU) / H.Fujita et al. / p549~549
  • General Lecture 254.Pharmacokinetics of UFT on Human Malignant Brain Tumors / K.Harada et al. / p549~549
  • General Lecture 255.Effect of UFT in Malignant Glioma (Part 1) -Concentration of FT-207 and 5-FU in Glioma Bearing Rat- / H.Nogaki et al. / p550~550
  • General Lecture 256.Study on Absorption of 5-FU Tablet / T.Kamano et al / p550~550
  • General Lecture 257.Study on Attainability of Oral 5-FU to Gynecological Cancer / K.Hattori et al. / p551~551
  • General Lecture 258.Clinical and Pharmacological Examination of Tegaful Continuous Intravenous Injection Therapy / T.Takasaki et al. / p551~551
  • General Lecture 259.5-FU Concentration in Various Tissue of the Patients Received FT-207 Prior to Operation / H.Sarashina et al. / p552~552
  • General Lecture 260.Preoperative Rectal Administration of FT-207 in Rectal Cancer / K.Hayashida et al. / p552~552
  • General Lecture 261.Concentration of FT-207 in Blood and Female Genital Tissues after Rectal Administration (I)--Correlation between Concentration in Blood and Tissues / H.Okazaki et al. / p553~553
  • General Lecture 262.Concentration of 5-FU Value in the Tissue and Blood of Breast Cancer Patients by Preoperative Administration of UFT / K.Suemasu et al. / p553~553
  • General Lecture 263.Clinical Study on Drug Delivery into Tumor Tissue by Using UFT / S.Arima et al. / p554~554
  • General Lecture 264.Intra-arterial Infusion of Adriamycin for the Treatment of the Locally Advanced Breast Cancer--Studies on the Concentration of Adriamycin in Serum, Normal Breast Tissues, Tumor Tissues and Lymph Nodes / Y.Takatsuka et al. / p554~554
  • General Lecture 265.Failure to Augment the Tissue Concentration of Adriamycin by Simultaneous Use of Urokinase / O.Izuno et al. / p555~555
  • General Lecture 266.Effects of BLM Administrated by Iontophoresis on Uterine Cervical Cancer / K.Koike et al. / p555~555
  • General Lecture 267.Effect of TCUK on Penetration of 5-FU into Tumor / H.Takada et al. / p556~556
  • General Lecture 268.Studies of the Concentration in the Tumor, Blood,and Abdominal Organs on the Combined Therapy with Tegafur and 5-FU / Y.Ashida et al. / p556~556
  • General Lecture 269.Histologic Effects of Oral Tegafur Administration in Gastric Cancer / J.Fujimoto et al. / p557~557
  • General Lecture 270.The Concentration of 5-FU Derivatives FD-I-E and THFU in Plasma and Stomach Tissue from Patients with Gastric Cancer / T.Ohno et al. / p557~557
  • General Lecture 271.Effect of DONU on Nine Human Carcinomas Transplanted to Nude Mice / F.Asanuma et al. / p558~558
  • General Lecture 272.Effect of Bleomycin and Pepleomycin(NK-631)to the Poorly Differentiated Transitional Cell Carcinoma Transplantable to the Nude Mice(NM-B-1) / N.Tsuboi et al. / p558~558
  • General Lecture 273.Antitumor Effects of Cis-platinum on Human Rhabdomyosarcoma Transplanted in Nude Mice / S.Masuda et al. / p559~559
  • General Lecture 274.A Study on Histopathological Changes of Testis by Cis-platinum Diamine Dichloride(CDDP)in Nude Mice Inoculated with Human Testicular Tumor / M.Tanino et al. / p559~559
  • General Lecture 275.Sensitivity of CDDP against Human Urogenital Malignant Neoplasms Transplantable to Nude Mice and Its Clinical Effects / M.Akimoto et al. / p560~560
  • General Lecture 276.Effect of Antitumor Agents against Human Tumor Xenografts Serially Transplanted to Nude Mice with Special Reference to Microangiography and Tumor Growth Rate / M.Okazaki et al. / p560~560
  • General Lecture 277.Sensitivity Test of Anticancer Agents of Human Hepatocellular Carcinoma Serially Transplanted to Nude Mice--With Special Reference to Difference in Sensitivity of Anticancer Agents to Three Strains / M.Kasajima et al. / p561~561
  • General Lecture 278.Sensitivity Test of Anticancer Agents of Human Hepatocellular Carcinoma Serially Transplanted to Nude Mice--With Special Reference to Administration Method of Anticancer Agents / S.Iida et al. / p561~561
  • General Lecture 279.Effects of MMC and 5FU on Nine Different Transplantable Strains of Humans Stomach Carcinomas in Nude Mice and the Results of Follow-up Studies on the Patients with Their Original Carcinomas / N.Miyagi et al. / p562~562
  • General Lecture 280.Characterization of a Cell Line(SGF-3)Derived from a Human Esophageal Carcinoma / T.Shinbo et al. / p562~562
  • General Lecture 281.Effects of Anticancer Drugs on Colony Formation of Cells from Cancer Tissue / T.Wada et al. / p563~563
  • General Lecture 282.Drug Sensitivity Test of Cultured Human Renal Cell Carcinomas by Regrowth Assay / T.Osawa et al. / p563~563
  • General Lecture 283.The Effect of Anticancer Drugs on Cell Cycle Progression in Human Bladder Cancer Cell Lines / O.Hashimoto et al. / p564~564
  • General Lecture 284.A Study on Sensitivity Testing of Ovarian Cancer Cells to Anticancer Chemotherapy--With Special Reference to Use of LDH and Its Isozymes as Indicators / H.Inui et al. / p564~564
  • General Lecture 285.Effect of Anti-AFP-daunomycin(DAM)Conjugate on the Growth of AFP Producing c-Hc-4 Cells / F.Sasaki et al. / p565~565
  • General Lecture 286.Effects of Bleomycin and Actinomycin D on a B-lymphoma Cell Line / M.Nishikori et al. / p565~565
  • General Lecture 287.Sensitivity of Four Bladder Cancer Cell Lines to Anticancer Drugs in vitro / H.Afuso et al. / p566~566
  • General Lecture 288.Not Received / /
  • General Lecture 289.A Preliminary Study for the Chemosensitivity Test Utilizing the Primary Short Term Culture with ³H-Thymidine / J.T.Chen et al. / p566~566
  • General Lecture 290.Experience of Preoperative Chemotherapy in Cancer of the Breast / K.Komuro et al. / p567~567
  • General Lecture 291.Histological Evaluation of Chemotherapy Effect for Preoperative Administration in Rectal Cancer / A.Ouchi et al. / p567~567
  • General Lecture 292.Histological Alterations in Esophageal Carcinoma by Bleomycin One-shot Arterial Injection with Special Reference to Nuclear DNA Conent / K.Maruta et al. / p568~568
  • General Lecture 293.Cytohistological Studies on the Effect of Long-term Maintenance chemotherapy / K.Yamamoto et al. / p568~568
  • General Lecture 294.Preoperative Treatment with OMF for Gastric Cancer / M.Mukai / p569~569
  • General Lecture 295.The Effects of Anticancerous Agents(Tegafur,UFT)Administered Preoperatively on Gastric Cancer / K.Okada et al. / p569~569
  • General Lecture 296.Relationship between Histological Changes of Gastric Cancer Receiving 5-FU Emulsion and Prognosis of the Patients / N.Mizuguchi et al. / p570~570
  • General Lecture 297.The Examination of Preoperative Chemotherapy for Gastric Cancer / K.Suzuki et al. / p570~570
  • General Lecture 298.Ultrastrural study on the Effects of Chemotherapy Applied to Human Gastric Cancer Cells / M.Sakaguchi et al. / p571~571
  • General Lecture 299.Fundamental Study on Depot-type Adriamycin Containing Contrast Medium for X-ray Examination / T.Okawa et al. / p571~571
  • General Lecture 300.The Local Therapy for Early Cervical Cancer--Comparative Studies on the Curerate between the Suppositories Made of Bleomycin Alone and of Bleomycin with 5-Fluorouracil or Carboquone / A.Kimura et al. / p572~572
  • General Lecture 301.Local Chemotherapy of Recurrent Head and Neck Cancer Patient by Bleomycin Ointment Combined with Membrane Active Agent / T.Nakashima et al. / p572~572
  • General Lecture 302.A Clinical Study of Release-controlled MMC Needle-type Preparation for Topical Cancer Chemotherapy / M.Nakamura et al. / p573~573
  • General Lecture 303. A Method for Local Application of Anti-cancer Drugs Using Collagen as a Drug Delivery Devise with Slow Release / T.Kubota / p573~573
  • General Lecture 304.Intravesical Chemotherapy for Superficial Bladder Cancer / M.Moriyama et al. / p574~574
  • General Lecture 305.By-pass Operation with Combined Radio and Chemotherapy in Non-resectable Esophagus Cancer / K.Namatame et al. / p574~574
  • General Lecture 306.Operation and Local Chemotherapy of Esophageal Cancer,Especially Esophageal Intubation with Bleomycin Coated Tube / T.Tanaka et al. / p575~575
  • General Lecture 307.Treatment of Esophageal Carcinoma by Oral Administration of Sodium Polyacrylate(PANa)Kayaku and Oil Bleomycin / T.Kamano et al. / p575~575
  • General Lecture 308.Combined Treatment of Advanced Carcinoma of Common Bile Duct / T.Kamata et al. / p576~576
  • General Lecture 309.A Clinical Study on the Administration of Adriamycin-Emulsion into the Bile Duct / T.Ito et al. / p576~576
  • General Lecture 310.Fundamental and Clinical Studies on Endoscopic Injection of Methyl-CCNU Emulsion for Gastric Cancer / H.Fujiwara et al. / p577~577
  • General Lecture 311.Clinical and Labolatory Evaluation of Steroid & Anti-cancer Drug Infusion Therapy for Malignant Effusion / M.Takahashi et al. / p577~577
  • General Lecture 312.Experimental and Clinical Study of Liposome-entrapped Anticancer Drugs / M.Tachibana et al. / p578~578
  • General Lecture 313.Intra-arterial Infusion of Micro-encapsulated Mitomycin C in the Treatment of Advanced Carcinoma / Y.Tsuji et al. / p578~578
  • General Lecture 314.Microencapsulated Mitomycin C Therapy in Unresectable Hepatoma and Liver Metastases of Miscellaneous Cancer / J.Itoh et al. / p579~579
  • General Lecture 315.Therapeutic Effect of Chemoembolisation with Mitomycin-microcapsules(MM-mc)for Renal Cell Carcinoma / H.Kato / p579~579
  • General Lecture 316.Not Received / /
  • General Lecture 317.Preoperative Superselective Transcatheter Vesical Arterial Embolization with Anti-cancer Agent in Bladder Carcinomas / S.Kimura et al. / p580~580
  • General Lecture 318.Not Received / /
  • General Lecture 319.Transcatheter Arterial Embolization Combined with Arterial Infusion for Hepatic Malignancies / J.Okamura et al. / p580~580
  • General Lecture 320.Treatment of Tumors with Ferromagnetic Microembolization--Clinical-Evalution in Hepatoma and Renal Cell Carcioma / S. Hirota et al. / p581~581
  • General Lecture 321.Effect of Transcatheter Arterial Embolization on Hepatocellular Carcinoma Patients / K.Soga et al. / p581~581
  • General Lecture 322.Not Received / /
  • General Lecture 323.Bronchial Arterial Infusion(BAI)for Multiple Lung Metastasis of Renal Cell Carcinoma / N.Miyazawa et al. / p582~582
  • General Lecture 324.Integrated Regional Chemotherapy and Surgery of Bladder Cancer--Regional Chemotherapy Given by Intraarterial Infusion with Concomitant Hemodialysis and Hemoperfusion / S.Kamidono et al. / p582~582
  • General Lecture 325.Experience of Intra-arterial Chemotherapy in the Advanced Cancer of the Digestive Organs / S.Murakami et al. / p583~583
  • General Lecture 326.Balloon-occluded Arterial Infusion--A New Method for Administration of Anticancer Drugs / S.Takashima et al. / p583~583
  • General Lecture 327.Intra-aortic Infusion Chemotherapy for Locally Recurrent Carcinoma of the Rectum / K.Yoshikawa et al. / p584~584
  • General Lecture 328.Use of Arterial Infusion of Neocarzinostatin as a Treatment for Carcinoma of the Prostate / A.Imagawa et al. / p584~584
  • General Lecture 329.Chemotherapy for Hepatocellular Carcinoma / Y.Okuyama et al. / p585~585
  • General Lecture 330.Metastatic Liver Tumor of Breast Cancer Treated with Intra-arterial Administration of Adriamycin and 5FU--A Case Report / R.Hosotani et al. / p585~585
  • General Lecture 331.The Treatment of Unresectable Liver Cancer by the Intermittent Hepatic Artery Occlusion and Infusion Chemotherapy / T.Tarumi et al. / p586~586
  • General Lecture 332.Blood Flow of Hepatoma Measured by Infusion of Kr-81m and Xe-133 via Catheter into Hepatic Artery / Y.Sasaki et al. / p586~586
  • General Lecture 333.The Therapeutic Effects of One Shot Intraarterial Infusion of Anti-neoplastic Agents for Liver Cancers / H.Hirose et al. / p587~587
  • General Lecture 334.The Effect of BLM-MMC-Lentinan(B-M-L)Arterial Infusion Therapy on Esophageal Cancer with Hepatic Metastasis / K.Okuyama et al. / p587~587
  • General Lecture 335.Combination Chemotherapy against Inoperable Liver Cancer (Primary and Secondary) -Study on the MQF-OK Therapy Including Intra-arterial Administration of Mitomycin-C and Carboquone- / Y.Sakata et al. / p588~588
  • General Lecture 336.Combination Chemotherapy with Adriamycin,Vincristine,Ifosfamide,and Prednisolone in the Treatment of Advanced Non-Hodgkin's Lymphoma / H.Ueoka et al. / p588~588
  • General Lecture 337.Effect of Cyclic VAMP Therapy for Advanced Malignant Lymphoma / S.Fukuhara et al. / p589~589
  • General Lecture 338.Clinical Trial of Combination Chemotherapy(CVP)in Advanced Non-Hodgkin's Lymphoma / I.Tanaka et al. / p589~589
  • General Lecture 339.High Dose Methotrexate Therapy on Lung Cancer and Malignant Lymphoma / H.Taguchi et al. / p590~590
  • General Lecture 340.High Dose Methotrexate with Leucovorin Rescue in the Treatment of Malignant Lymphoma / K.Sampi et al. / p590~590
  • General Lecture 341.Phase II and III Study with Vindesine in 50 Patients with Hematologic Malignancies / Y.Kubota et al. / p591~591
  • General Lecture 342.Not Received / /
  • General Lecture 343.Preventive Therapy of Central Nervous System Involvement in Childhood Acute Lymphocytic Leukemia (ALL) / J.Mimaya / p591~591
  • General Lecture 344.NCVP Therapy for Relapse of Acute Non-lymphocytic Leukemia Resistant to DCMP Therapy / Y.Karitani et al. / p592~592
  • General Lecture 345.Pharmacokinetics of Behenoyl-ara-C(BHAC)and Its Clinical Effects in Acute Leukemia / T.Ueda et al. / p592~592
  • General Lecture 346.Combination Therapy of Aclacinomycin A and BH-AC in Previously Untreated Patients with Acute Non-lymphocytic Leukemia / K.Sampi et al. / p593~593
  • General Lecture 347.Not Received / /
  • General Lecture 348.C.A.F.and/or C.M.F.Chemotherapy for Advanced Breast Cancer / J.Hirose et al. / p593~593
  • General Lecture 349.CAF Therapy for Advanced and Recurrent Breast Cancer / K.Enomoto et al. / p594~594
  • General Lecture 350.Hormono-chemotherapy of Breast Cancer with Cyclophosphamide,Adriamycin and Prednisolone (CAP) / Y.Nakamura et al. / p594~594
  • General Lecture 351.ACOP Combination Chemotherapy Consisting of Adriamycin,Cyclophosphamide,Oncovin(Vincristine)and Predonisolone for Recurrent and Advanced Breast Cancer / I.Yokoyama et al. / p595~595
  • General Lecture 352.Effects of Adriamycin to the Recurrence of the Breast Cancer / S.Hosoe et al. / p595~595
  • General Lecture 353.Sequential Endocrine-chemotherapy for Advanced Breast Cancer / Y.Nomura et al. / p596~596
  • General Lecture 354.The Five-year End Results of Operated Breast Cancer Patients Treated by Prolonged Cyclic Chemotherapy Especially Four Drug Combination (FEMP) / K.Endo et al. / p596~596
  • General Lecture 355.Mitomycin C,Methotrexate,Vincristine(MMV)Combination Chemotherapy for Advanced Breast Cancer Refractory to Adriamycin / K.Kanda et al. / p597~597
  • General Lecture 356.Effects of Long-term Oral Administration of Anti-cancer Drug to the Patients Treated with Non-curative Operation / S.Soejima et al. / p597~597
  • General Lecture 357.Combination Chemotherapy(5FU,Adriamycin and ACNU)in Advanced Gastrointestinal Cancer / J.Ishiwata et al. / p598~598
  • General Lecture 358.Clinical Evaluation of Combination Chemotherapy of Aclacinomycin A(ACM)and 5-Fluorouracil(5Fu)for Advanced Carcinoma of Gastrointestinal Tract / K.Kikuchi et al. / p598~598
  • General Lecture 359.A Four Drug Combination(MACC)Chemotherapy for Advanced or Recurrent Malignant Tumor / T.Matsunaga et al. / p599~599
  • General Lecture 360.Chemotherapy of Advanced Gastric Cancer / T.Satomi et al. / p599~599
  • General Lecture 361.Adriamycin/Mitomycin/Futraful Combination Chemotherapy for Advanced Carcinoma of the Stomach / Y.Kondoh et al. / p600~600
  • General Lecture 362.Postoperative Adjuvant Chemo-therapy of Advanced Stomach Cancer / Y.Furuta et al. / p600~600
  • General Lecture 363.Multihospital Randomized Study: Adjuvant Chemotherapy with Mitomycin-C and Futraful for Gastric Cancer VI.Estimation of Five-year Survival Rate / T.Kondo et al. / p601~601
  • General Lecture 364.Not Received / /
  • General Lecture 365.FQC Chemotherapy for Primary Ovarian Cancer / I.Takamura et al. / p601~601
  • General Lecture 366.UFT-M Chemotherapy for Ovarian Cancer(No.1) / T.Miwa et al. / p602~602
  • General Lecture 367.CAPF Combination Chemotherapy and Second-look Operation for the Treatment of Recurrent and Disseminated Malignant Tumor of Ovary / J.Inagaki et al. / p602~602
  • General Lecture 368.Not Received / /
  • General Lecture 369.Evaluation of Delayed Surgery for Gestational Choriocarcinoma / T.Tsukahara et al. / p603~603
  • General Lecture 370.An Aspect of the Intravenous Drop Infusion of Adriamycin(Part1) / H.Masuda et al. / p603~603
  • General Lecture 371.Experience of Combined Chemotherapy in Non-seminomatous Testicular Cancer / Y.Maruyama et al. / p604~604
  • General Lecture 372.Combined Surgery and Chemotherapy in Treatment of Stage I,II Testicular Tumors / S.Arakawa et al. / p604~604
  • General Lecture 373.Clinical Evaluation of Vinblastine Sulfate(VBL)in Renal Cell Carcinoma / Y.Saitoh et al. / p605~605
  • General Lecture 374.A Clinical Trial of Combination Chemotherapy with VCR,BLM,MMC,FT-207 and OK-432 in Urothelial Tumor / S.Fujihiro et al. / p605~605
  • General Lecture 375.Clinical Effect of UFT on Bladder Tumor / H.Kumon et al. / p606~606
  • General Lecture 376.Combination Chemotherapy with Multiple Agents of VPM-CisCF for Urogenital Malignancies / T.Yamauchi et al. / p606~606
  • General Lecture 377.Clinical and Experimental Studies on the Immunotherapy with Intradermal Injections of OK-432 / T.Kudo et al. / p607~607
  • General Lecture 378.Effect of Intraperitoneal Administration of OK-432 in Patients with Ascitic Gynecologic Tumor / N.Umesaki et al. / p607~607
  • General Lecture 379.Effect of Hypertranfusion and OK-432 on Blood Granulocyte Recovery / T.Nomura et al. / p608~608
  • General Lecture 380.Influence of Surgical Trauma on Cell-mediated Immunity and Tumor Growth / H.Kaneko et al. / p608~608
  • General Lecture 381.Effects of Various Immunostimulators on Carcinogenesis in Rats by Administration of MNNG / H.Shimizu et al. / p609~609
  • General Lecture 382.Effect of Immunomodulators on Natural Killing Activity / T.Akao et al. / p609~609
  • General Lecture 383.Immunotherapeutic Effects of Immune RNA on Methylcholanthrene-induced Fibrosarcomas in Balb/c Heteromice / S. Nomi et al. / p610~610
  • General Lecture 384.Active Specific Immunotherapy with 3M KCI Solubilized TSTA from Methylcholanthrene-induced Murine Sarcoma / T. Tanaka et al. / p610~610
  • General Lecture 385.NK Cell Activity of Malignant Brain Tumor Patients Treated with Interferon / T.Arai et al. / p611~611
  • General Lecture 386.Therapeutic Effect of Interferon and Interferon Inducer(Poly ICLC)in the Malignant Brain Tumor / O. Nakamura et al. / p611~611
  • General Lecture 387.Pilot Study of Fibroblast Interferon in Human Metastatic Breast Cancer / K.Wakasugi et al. / p612~612
  • General Lecture 388.Clinical Studies of Human Lymphocyte Interferon(Hu-IFN-a)Combined with Radiotherapy,Chemotherapy and Immunotherapy for 6 Cancer Patients / T.Miyoshi et al. / p612~612
  • General Lecture 389.The Change of Nuclear DNA Distributions on Murine Neuroblastomas Treated with Interferon and Cyclophosphamide / T.Tanaka et al. / p613~613
  • General Lecture 390.Combination Therapy of Interferon and Cyclophosphamide on Murine Neuroblastoma / M.Tozawa et al. / p613~613
  • General Lecture 391.Immunotherapy with Levamisole for Hepatocellular Carcinoma / K.Hojo et al. / p614~614
  • General Lecture 392.Immunochemotherapy in the Treatment of Hepatocellular Carcinoma / M.Tomita et al. / p614~614
  • General Lecture 393.Studies on Preoperative Immunotherapy for Gastric Cancer--The Effect of Immunostimulant"Levamisole" for the Regional Lymphnode / T.Kobori et al. / p615~615
  • General Lecture 394.Immunochemotherapy of Gastric Cancer / F.Ono et al. / p615~615
  • General Lecture 395.Evaluation of Levamisole (LMS) against Advanced Gastrointestinal Cancer by Cooperative Study / A.Wakui et al. / p616~616
  • General Lecture 396.Analysis of Gastric and Colorectal Cancer Cases at Stages III,IV,and V in which Postoperative Treatment with PSK Plus 5-FUDS was Done for One Year or Longer / S.Saji et al. / p616~616
  • General Lecture 397.Postoperative Long-term Adjuvant Immunochemotherapy in Gastric Cancer Patients / M.Oride et al. / p617~617
  • General Lecture 398.Comparison Studies on MQF-OK Therapy and MFC Therapy against Inoperable Gastric Cancer / Y.Sakata et al. / p617~617
  • General Lecture 399.Clinical Evaluation of Postoperative Chemotherapy,Immunotherapy,Immunochemotherapy in Advanced Gastric Cancer (Concerning Noncurative Resection and Non Resected Cases) / T.Taira et al. / p618~618
  • General Lecture 400.Combination Immuno Chemotherapy of Inoperable Gastric Cancer with 5-FU,ACNU,OK-432 / M.Tatewaki et al. / p618~618
  • General Lecture 401.Evaluation of Direct Injection of OK-432into Hepatoma / S.Imaoka et al. / p619~619
  • General Lecture 402.Combination Therapy of Advanced Cancer of Digestive Organs with OK-432,MMC,PSK and FT-207 / T.Yamaguchi et al. / p619~619
  • General Lecture 403.Immunochemotherapy of Lung Cancer
  • Effects of OK-432 on Monocyte Functions / N.Noda et al. / p620~620
  • General Lecture 404.Not Received / /
  • General Lecture 405.Studies on the Treatment of Cancer with the Combined Chemotherapy and Immunotherapy / I.Shima et al. / p620~620
  • General Lecture 406.The Combination Therapy(Intratumoral Large Dose of OK-432,Irradiation and Chemotherapy)of the Cancer of Cervix Uteri / M.Saito / p621~621
  • General Lecture 407.Maintenance Immuno-Chemotherapy for Cervical Carcinoma--A Comparative Study of OK-432 and Levamizole / H.Taniguchi et al. / p621~621
  • General Lecture 408.Clinical Effect of Immunopotentiators in Uterine Cervical Cancer / K.Kanazawa et al. / p622~622
  • General Lecture 409.Study on Cellular Immune Reactivities in the Patients with Advanced Cervical Cancer after Treatments Part 3: Comparison Study between Non-immunotherapeutic and Immunotherapeutic Groups / K.Hasegawa et al. / p622~622
  • General Lecture 410.A Peripheral Monocytic Effect in Patients with Cervical Carcinoma Following Immunopotential Therapy / M.Kaneko et al. / p623~623
  • General Lecture 411.Applicability of Lentinan to the Adrenalectomized Patients with Advanced Breast Cancer: Fundamental Study on the Adrenalectomized Rats / A.Kosaka et al. / p623~623
  • General Lecture 412.Experience of Vitamine B6 Therapy for Gastrointestinal Malignancy as Host Defense Stimulator / H.Sugiura et al. / p624~624
  • General Lecture 413.Two Cases of Long Survival with Malignant Glioma Treated by Immunotherapy Using Lymphocytes sensitized with Tumor-specific Immune RNA / R.Mita et al. / p624~624
  • General Lecture 414.Gastric Cancer Therapy Combined with N-CWS Administration by Endoscopy / A.Matsumi et al. / p625~625
  • General Lecture 415.BCG Immunotherapy in Patients with Carcinoma of the Oral Cavity in Our Department / H.Fukazawa et al. / p625~625
  • General Lecture 416.Statistical Reviews on the Clinical Results of Advanced Cancer Patients Treated with an Extract from Human Tubercle Bacilli (Maruyama Vaccine,S.S.M.) (Report III) / K.Fujita et al. / p626~626
  • General Lecture 417.Immunochemotherapy with SSM,an Extract from Mycobacterium Tuberculosis Strain Aoyama B,in Advanced Cancer:Evaluation of Clinical Effects of SSM by a Double-blind Test / N.Nomura et al. / p626~626
  • General Lecture 418.Intraoperative Radiotherapy in the Treatment of Carcinoma of the Pancreas / M.Yasue et al. / p627~627
  • General Lecture 419.Intraoperative Irradiation Combined with Radical Resection for Cancer of the Head of the Pancreas / T.Hiraoka et al. / p627~627
  • General Lecture 420.Clinical Results of Fast Neutron Radiotherapy for Carcinoma of the Gastrointestinal Tracts / T.Ishikawa et al. / p628~628
  • General Lecture 421.A Judgment on the Histological Effects of Preoperative Irradiation for Advanced Gastric Carcinoma / H.Joko et al. / p628~628
  • General Lecture 422.Autopsy Cases of Radiotherapy of Inoperable Gastric Cancer / S.Takashima et al. / p629~629
  • General Lecture 423.Radiation Therapy of Malignant Obstructive Jaundice / Y.Hishikawa et al. / p629~629
  • General Lecture 424.The Observation of Early Reaction in Radiotherapy of Carcinoma of the Tongue / S.Matsuura et al. / p630~630
  • General Lecture 425.Interstitial Radiotherapy of the Tongue Cancer by Iridium-192 / M.Takeda et al. / p630~630
  • General Lecture 426.Analysis of Treatment in Carcinoma of the Mobile Tongue Regarding Local Control and Complications / S.Takinami et al. / p631~631
  • General Lecture 427.The Result of Radiotherapy of Nasopharyngeal Carcinoma / K.Nishiyama et al. / p631~631
  • General Lecture 428.Subjects of ¹³¹I Therapy for a Differentiated Type of the Thyroid Cancer with Distant Metastasis / M.Miyakawa et al. / p632~632
  • General Lecture 429.A Case of an Aged Lung Cancer Patient Treated with Repeated Intraoperative Irradiation / T.Nakatsu et al. / p632~632
  • General Lecture 430.Clinical Experiences of Treatment for Primary Lung Cancer by Fast Neutron / Y.Iino et al. / p633~633
  • General Lecture 431.Analysis on Preoperative Combined Bleomycin and Radiation Therapy for Esophageal Carcinoma / O.Tanaka et al. / p633~633
  • General Lecture 432.Therapeutic Results and Long Survival Factors of Patients with Esophageal Cancers Treated with Radiotherapy Alone / T.Nakano et al. / p634~634
  • General Lecture 433.The Analysis of 5 Years Survivors by Radiotherapy Alone / M.Hareyama et al. / p634~634
  • General Lecture 434.Bigger Dose Radiotherapy in Treatment of Glioblastoma / Y.Maehara et al. / p635~635
  • General Lecture 435.Lymphocytic Lymphoma Treated by Total Body Irradiation / T.Yamashita et al. / p635~635
  • General Lecture 436.Radiotherapy of Cancer of Prostate / T.Nagayama et al. / p636~636
  • General Lecture 437.Radiation Therapy of Carcinoma of the Vulva / T.Arai et al. / p636~636
  • General Lecture 438.Radiation Therapy of Uterine Cervical Cancer in Our Hospital / M.Hirono et al. / p637~637
  • General Lecture 439.Comparison with the Radiotherapy Complications between Non-recurrent Group and Recurrent Group of Uterine Cervix Cancer / E.So et al. / p637~637
  • General Lecture 440.Intracavitary Therapy of Uterine Carcinoma Using the Remotely Controlled Afterloading Unit(Gynatron)with Low Dose-rate Irradiation / Y.Tanaka et al. / p638~638
  • General Lecture 441.Investigation of Rectal Injury and Limiting Factors of RALS-therapy to Carcinoma of the Uterine Cervix / T.Inoue et al. / p638~638
  • General Lecture 442.Clinical Experiences with Californium C5-252 for Cervical Carcinoma / K.Fukuda et al. / p639~639
  • General Lecture 443.Use of CT in Radiation Treatment of Cervical Carcinoma: Evaluation of Nodal Metastases / C.Kanehira et al. / p639~639
  • General Lecture 444.Evaluation of the External Irradiation Using the Comformation Technique on the Uterine Carcinoma(2nd Report) / A.Murakami et al. / p640~640
  • General Lecture 445.Clinical Significance of the Computer Controlled Conformation Radiotherapy / T.Matsuda et al. / p640~640
  • General Lecture 446.Clinical Trial of Radioprotector YM-08310 / I.Takahashi et al. / p641~641
  • General Lecture 447.Modifying Effects of Defibrinatic Agents on Radiation to Malignant Tumor in Mice and Human / T.Miyoshi et al. / p641~641
  • General Lecture 448.Clinical Trial of Hypoxic Cell Radiosensitizer Misonidazole / I.Takahashi et al. / p642~642
  • General Lecture 449.Clinical Study of Misonidazole Used as Pretreatment for X-ray Therapy for Cancer of the Cervix Uteri / T.Kitamura et al. / p642~642
  • General Lecture 450.Response to Radiation of Human Hepatoblastoma Xenograft in Nude Mice / M.Tanabe et al. / p643~643
  • General Lecture 451.Prophylactic Effect of α-tocopherol on Intestinal Radiation Injury in Patient with Gynecologic Cancer / Y.Watanabe et al. / p643~643
  • General Lecture 452.Radiation-induced Cancer of the Head and Neck Lesion-analysis of Its Clinical Frequency / K.Ichikawa et al. / p644~644
  • General Lecture 453.Effect of Concomitant Use of Immunomodulator(OK-432 and/or PSK)on Advanced Lung Cancer (Squamous Cell Carcinoma and Adenocarcinoma)Treated with Radiation with Combined Chemotherapy / Y.Ogawa et al. / p644~644
  • General Lecture 454.Role of Host's Immunity in Experimental Radiotherapy on Syngeneic Solid Tumors Transplanted to BALB/c Mice / K.Tsuyuki et al. / p645~645
  • General Lecture 455.Effectiveness of Hyperthermo-Chemo-Radiotherapy for Treatment of Carcinoma / H.Kai et al. / p645~645
  • General Lecture 456.A case of Hyperthermotherapy which Showed Remarkable Efficacy in a Patient with Recurrent Gastric Cancer / H.Honma et al. / p646~646
  • General Lecture 457.Hyperthermic Treatment for the Bladder Tumor Effect of Hyperthermic Irrigation with Lidocaine-enriched Saline / S.Kiyotaki et al. / p646~646
  • General Lecture 458.Hyperthermic Treatment for the Bladder Cancer: Combined Hyperthermic Treatment with Futraful and Picibanil / I.Murahashi et al. / p647~647
  • General Lecture 459.Local Hyperthermia Treatment of Advanced Cancer / K.Tari et al. / p647~647
  • General Lecture 460.Hyperthermic Therapy of the Bladder Cancer / Y.Kubota et al. / p648~648
  • General Lecture 461.Clinical Application of Hyperthermia to Treatment for Carcinoma of the Cervix (Fundamental Study on the Uterine Cervix Heating Apparatus) / T.Miura et al. / p648~648
  • General Lecture 462.Histopathological Studies on the Effect of Hyperthermia for Cervical Cancer / T.Kagabu et al. / p649~649
  • General Lecture 463.Experimental Studies of Selective Hyperthermia Using Induction Heating / S.Yokogawa et al. / p649~649
  • General Lecture 464.The Treatment of Malignant Brain Tumors by a Radiofrequency Conductive Heating / C.H.Kim et al. / p650~650
  • General Lecture 465.Experimental Studies on Thermochemotherapy / J.Miyao et al. / p650~650
  • General Lecture 466.Combined Microwave (433 MHz,2450 MHz) and Radiation Therapy on Patients with Advanced Cancer / Y.Ohizumi et al. / p651~651
  • General Lecture 467.Clinical Evaluation of Combination Therapy of Localized Hyperthermia by Microwaves and Chemotherapy for Far-advanced Carcinomas / T.Saito et al. / p651~651
  • General Lecture 468.Thermotherapy in Combination with Radiotherapy for the Treatment of Radioresistant Tumors / M.Hiraoka et al. / p652~652
  • General Lecture 469.Experimental Studies on Topical Therapy for Bladder Carcinoma III.Microwave lrradiation Enhanced with Magnetically Controlled Ferrite Particles / H.Mori et al. / p652~652
  • General Lecture 470.Clinical Experiences of Hyperthermia Cancer Therapy with Microwave / J.Egawa et al. / p653~653
  • General Lecture 471.Total Body Hyperthermia Using Extracorporeal Circuit for Disseminated Cancer Patients / M.Maeta et al. / p653~653
  • General Lecture 472.Extracorporeally Induced Systemic Hyperthermia / N.Kato et al. / p654~654
  • General Lecture 473.Cardio-pulmonary Responses and Hematological Changes in Systemic Hyperthermia / M.Hosoi et al. / p654~654
  • General Lecture 474.Multi-disciplinary Cancer Treatments Including Extracorporeally Induced Systemic Hyperthermia / K.Ota et al. / p655~655
  • General Lecture 475.Not Received / /
  • General Lecture 476.Hormone Receptors in Human Breast Cancer / H.Sonoo et al. / p655~655
  • General Lecture 477.The Effect of Medroxyprogesterone Acetate(MAP)for Recurrent and Advanced Breast Cancer / T.Okumoto et al. / p656~656
  • General Lecture 478.Effects of Oral High Dose Administration of Medroxyprogesterone Acetate(MAP)and Hexestsol on the Postmenopausal Patients with Advanced Breast Cancer / M.Kitamura et al. / p656~656
  • General Lecture 479.Chemo-endocrine Therapy for Advanced Breast Cancer--A Combined Therapy with Tamoxifen,Tegafur and Cyclophosphamide / T.Wada et al. / p657~657
  • General Lecture 480.Relationship between Sex Steroid Hormone Receptors in Renal Cell Carcinoma and Patient Survival / E.Nakano et al. / p657~657
  • General Lecture 481.Prognosis of Anti-androgen Therapy and Clinico-pathological Observation in Prostatic Cancer / S.Hoshi et al. / p658~658
  • General Lecture 482.Endocrine Therapy for Prostatic Cancer / M.Maruoka et al. / p658~658
  • General Lecture 483.A Statistical and Clinical Study on Prostatic Carcinoma at Okayama University Hospital / T.Tsushima et al. / p659~659
  • General Lecture 484.Microwave Coagulation Therapy for Tumors / K.Tabuse et al. / p659~659
  • General Lecture 485.Results of Follow-up Work on Cervical Intraepithelial Neoplasis after CO₂ Laser Irradiation / K.Sakamoto et al. / p660~660
  • General Lecture 486.Endoscopic Laser Treatment of Gastrointestinal Tumors(The Fifth Report) / Y.Ito et al. / p660~660
  • General Lecture 487.Clinical Application of Nd-YAG Laser in Patients with Gastric and Lung Cancer / S.Suzuki et al. / p661~661
  • General Lecture 488.The Effect of Nd-YAG Laser on MNNG Induced Gastric Cancers in Rats / M.Sasako et al. / p661~661
  • General Lecture 489.Synergistic Effect of Intra Venous Hyperalimentation and Intra-arterial Infusion Cancer Chemotherapy / M.Inawashiro et al. / p662~662
  • General Lecture 490.Effect of Chemotherapy Combined with TPN as an Adjunct to an Operation of Advanced Gastric Cancer / N.Yamada et al. / p662~662
  • General Lecture 491.Effects of Parenteral Nutrition on the Metabolism of Chemotherapeutic Agent / M.Kimoto et al. / p663~663
  • General Lecture 492.Experimental Study on the Effects of IVH(Intravenous Hyperalimentation)and Chemotherapy upon the Tumor Growth / H.Shigeta et al. / p663~663
  • General Lecture 493.Use of Elemental Diet for Nutritional Management of the Patients with Head and Neck Tumors / A.Saito et al. / p664~664
  • General Lecture 494.Effect of Amino Acid Imbalanced Elemental Diet on the Growth of C3H Mouse Fibro Sarcoma / S.Usui et al. / p664~664
  • General Lecture 495.Plasmapheresis in Patients with Advanced Gynecological Malignancies / T.Kajino et al. / p665~665
  • General Lecture 496.Clinical Experience of Plasmapheresis in Patients with Advanced Cancer / T.Okumura et al. / p665~665
  • General Lecture 497.Plasmapheresis in Patients with Disseminated Cancer Studies on Immunological Parameters / H.Kono et al. / p666~666
  • General Lecture 498.Prognosis of Extranodal Lymphomas / Y.Tamaki et al. / p666~666
  • General Lecture 499.Malignant Lymphoma of the Nasal Cavity and Paranasal Sinus / S.Ushiro et al. / p667~667
  • General Lecture 500.Studies on the Clinical pictures of Malignant Lymphomas of the Thyroid / M.Miyakawa et al. / p667~667
  • General Lecture 501.Surgical Treatment for the Gastrointestinal Malignant Lymphoma / S.Ikeuchi et al. / p668~668
  • General Lecture 502.On the Significance of Multiagent Chemotherapy for Primary Gastric Malignant Lymphoma / T.Takenaka et al. / p668~668
  • General Lecture 503.Prognosis of Non-Hodgkin's Lympboma According to Pathological Classifications / M.Miyamoto et al. / p669~669
  • General Lecture 504."Silent"Brain Metastasis of Malignant Tumors / J.Uki et al. / p669~669
  • General Lecture 505.Successful Therapy of Cerebral Metastasis of Gestational Choriocarcinoma. A Case Report / T.Morizuka et al. / p670~670
  • General Lecture 506.CNS Metastases in Patients with Advanced Breast Cancer / T.Nagata et al. / p670~670
  • General Lecture 507.Result of the Treatment for Metastatic Brain Tumor / M.Kitahara et al. / p671~671
  • General Lecture 508.Evaluation of Conservative Treatment for Squamous Cell Carcinoma of the Oral Cavity,Except the Tongue / S.Makino et al. / p671~671
  • General Lecture 509.Lymph Nodes Metastases of Tongue Carcinomas / T.Watanabe et al. / p672~672
  • General Lecture 510.The Analysis of the Factors of Prognosis in Carcinoma of the Tongue / B.Satake et al. / p672~672
  • General Lecture 511.Malignant Hemangiopericytoma of the Mandibular Alveolar Process--A Case Report / Y.Endoh et al. / p673~673
  • General Lecture 512.Local Treatment for Recurrence of Head and Neck Cancer / K.Inoue et al. / p673~673
  • General Lecture 513.Treatment of Advanced Aged Patients over 80 with Head and Neck Cancers / K.Yoshino et al. / p674~674
  • General Lecture 514.Bleo-VEMF'HA(BLM,VCR,EX,MTX,FH,Predonin and ADM) Synchronized Chemotherapy,and Its Modified Chemotherapy(Used CQ Instead of EX) / M.Ohkawa et al. / p674~674
  • General Lecture 515.The Operations Limit and More Wide Technic of the Advanced Thyroid Surgery / H.Goto et al. / p675~675
  • General Lecture 516.Factors Influencing on the Survival in Operated Thyroid Carcinoma / H.Nakajima et al. / p675~675
  • General Lecture 517.The Experimental Study on the Suppressive Effect for the Pulmonary Metastasis of the Arterial-infusion of Adriamycin / A.kato et al. / p676~676
  • General Lecture 518.Treatment of Pulmonary Metastasis of Osteosarcoma / S.Yamawaki et al. / p676~676
  • General Lecture 519.Treatment of Recurrent and Metastatic Bone and Soft Tissue Tumors / S.Yoh et al. / p677~677
  • General Lecture 520.Surgical Therapy of Lung Cancer: Results of Palliative Resection / I.Takagi et al. / p677~677
  • General Lecture 521.Evaluation of Limited Operation for Lung Cancer / K.Shibata et al. / p678~678
  • General Lecture 522.Treatment of the Intolerable Pain in Far-advanced Lung Cancer--Effects of the Brompton Mixture / k.Ninomiya et al. / p678~678
  • General Lecture 523.Cancer in Remnant Stomach (Mainly on Resected Cases) / T.Imada et al. / p679~679
  • General Lecture 524.Therapy of pm Gastric Cancer / H.Nomura.et al. / p679~679
  • General Lecture 525.The Three and Five Years Survival Rates for Gastric Cancer after Gastrectomy / N.Tajima et al. / p680~680
  • General Lecture 526.Treatment of Gastric Cancer in the High Aged / H.Umemura et al. / p680~680
  • General Lecture 527.Surgical Treatment and Combined Radiotherapy for Esophageal Carcinoma / H.Otani et al. / p681~681
  • General Lecture 528.Treatment of"Early"and"Superficial"Esophageal Cancer / K.Koseki et al / p681~681
  • General Lecture 529.Postoperative Complication and Complaint of Transabdominal Resection of Esophagocardial Cancer with By-pass Method / Y.Miyoshi et al. / p682~682
  • General Lecture 530.Examinations of the Resected Cases by Pancreaticoduodenectomy with Resection of the Portal Vein in Periampullary Cancer / R.Ohyama et al. / p682~682
  • General Lecture 531.Carcinoma of the Extrahepatic Bile Ducts--A Histopathologic Study / K.Shinmura et al. / p683~683
  • General Lecture 532.Diagnosis and Treatment for Cholangiocellular Carcinoma of the Liver / T.Sanda et al. / p683~683
  • General Lecture 533.Clinicopathological Studies of Minute Hepatocellular Carcinoma--Analysis of 7 Resected Cases / T.Yoshikawa et al. / p684~684
  • General Lecture 534.Postoperative Care of Hepatectomized Patients--Clinical Application of Metabolic Liver Assist / Y.Kono et al. / p684~684
  • General Lecture 535.Surgical Treatment to the Recurrence of the Rectal Carcinoma / H.Eguchi et al. / p685~685
  • General Lecture 536.Clinicopathological Study on Combined Resection of the Adjacent Organs for Colorectal Cancer / T.Sekine et al. / p685~685
  • General Lecture 537.Long Survivals Following Total Pelvic Exenteration for Advanced Rectal Cancer / H.Takagi et al. / p686~686
  • General Lecture 538.Therapy of Carcinoids of the Large Intestine / M.Kameyama et al. / p686~686
  • General Lecture 539.Management of Advanced Bladder Carcinoma / M.Iguchi et al. / p687~687
  • General Lecture 540.Multidisciplinary Treatment of Advanced Bladder Cancer / Y.Matsumura et al. / p687~687
  • General Lecture 541.Total Cystectomy for Bladder Cancer and Its Prognosis / T.Igarashi et al. / p688~688
  • General Lecture 542.Statistical Studies on Partial Cystectomy for Bladder Cancer / T.Kobayashi et al. / p688~688
  • General Lecture 543.Treatment of Carcinoma of the Urachus / T.Kakizoe et al. / p689~689
  • General Lecture 544.Clinical Management of Carcinoma in Situ of the Bladder / H.Itatani / p689~689
  • General Lecture 545.Operative Treatment of the Bladder Cancer: Clinical Aspects of the Carcinoma in Situ / M.Nakazono et al. / p690~690
  • General Lecture 546.Prognosis of Low Grade,Low Stage Carcinoma of the Bladder / T.Miura et al. / p690~690
  • General Lecture 547.lndication of Therapeutic Conization to Early Cervical Cancer and Fertility after Treatment / S.Moriya et al. / p691~691
  • General Lecture 548.Reproductive Performance of Women after Chemotherapy of Trophoblastic Disease / N.Shinkai et al. / p691~691
  • General Lecture 549.Experimental Study on Urethral Disorders after Operation of Cervical Cancer / A.Kurokawa et al. / p692~692
  • General Lecture 550.Neutrophils Function in Post Operative Retroperitoneal Space Exudate after Radical Hysterectomy for Cervical Cancer / A.Ito et al. / p692~692
  • General Lecture 551.Ways to Prevent Complications of Pelvic Exenteration / N.Tsukamoto et al. / p693~693
  • General Lecture 552.Therapeutic Limits of Local Treatment (Radical Hysterctomy and Pelvic Lymphnode Dissection) -Necessity of Additional Systemic Therapy in the Uterine Cervical Cancer- / H.Masaoka et al. / p693~693
  • General Lecture 553.Malignant Ovarian Tumors in Young Women / M.Yamasaki et al. / p694~694
  • General Lecture 554.Not Received / /
  • General Lecture 555.Effects of Chemotherapy and Surgical Treatment on Choriocarcinoma / T.Maruo et al. / p694~694
  • General Lecture 556.Surgical Management in the Primary Management of Hydatidiform Mole / K.Kawagoe et al. / p695~695
  • General Lecture 557.Effects of Chemotherapy and Surgical Treatment on Invasive Mole / A.Harada et al. / p695~695
  • General Lecture 558.Studies on 106 Cases of Hydatidiform Mole(HM)Interrupted and Followed up in Our Hospital / T.Hando et al. / p696~696

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology

Nihon gan chiryo gakkaishi
巻冊次 17(2)
出版元 日本癌治療学会
刊行年月 1982-03
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想